Cost of Achieving Relevant Composite Endpoint of HbA1c<7%, No Hypoglycaemia and Weight Loss of ≥3% in a 52 Week Post-Hoc Analysis of Dapagliflozin Versus Glipizide (Englisch)
- Neue Suche nach: Bergenheim, K.
- Neue Suche nach: Grandy, S.
- Neue Suche nach: Wygant, G. D.
- Neue Suche nach: Bergenheim, K.
- Neue Suche nach: Grandy, S.
- Neue Suche nach: Wygant, G. D.
In:
VALUE IN HEALTH
;
16
, 7
;
A439
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Cost of Achieving Relevant Composite Endpoint of HbA1c<7%, No Hypoglycaemia and Weight Loss of ≥3% in a 52 Week Post-Hoc Analysis of Dapagliflozin Versus Glipizide
-
Beteiligte:
-
Erschienen in:VALUE IN HEALTH ; 16, 7 ; A439
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:A439
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 16, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A323
-
Responsiveness of the EQ-5D in Oncology: A Meta-AnalysisSmith, A. B. / Cocks, K. / Taylor, M. / Parry, D. et al. | 2013
- A324
-
The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical ModellingParham, P. E. / Hughes, D. A. et al. | 2013
- A325
-
Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure: Application in Parkinson’s DiseaseNeine, M. / Briquet, B. / Mokdad, C. E. / Vataire, A. L. / Aballea, S. et al. | 2013
- A326
-
A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)Pennington, B. / Batty, A. J. / Clifton-Brown, E. et al. | 2013
- A327
-
Application of Behavioural Economics to the Understanding of Adherence: Does an Individual’s Time Preference Influence Adherence to Medications?Fargher, E. A. / Morrison, V. / Plumpton, C. O. / Hughes, D. A. et al. | 2013
- A328
-
Quality Criteria for the Development of Implant RegistriesNiederländer, C. S. / Wahlster, P. / Kriza, C. / Schaller, S. U. / Kolominsky-Rabas, P. L. et al. | 2013
- A329
-
Mapping the CCQ onto EQ-5D Scores (Im)Possible?Boland, M. R. / van Boven, J. F. / Rutten-van Mölken, M. P. et al. | 2013
- A330
-
Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids: A Systematic Review and Indirect Treatment ComparisonPanagiotopoulou, N. / Nethra, S. / Karabis, A. / Ahmad, G. / Burls, A. et al. | 2013
- A331
-
Budget Impact of Dienogest in Treating Endometriosis Associated Pelvic Pain in Brazil: A Public Perspective AnalysisFerracini, M. / Nakada, C. P. et al. | 2013
- A332
-
A Cost of a Childbirth with in vitro Fertilization in PolandGóra, K. / Hermanowski, T. / Wrona, W. et al. | 2013
- A333
-
Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in BrazilDecimoni, T. C. / Sansone, D. / Etto, H. / Santos, A. M. / Araújo, G. / Fonseca, E. S. / Fonseca, M. et al. | 2013
- A334
-
Cost Minimization Analysis of the Dienogest Use in Patients with Endometris under Brazilian Public and Private PerspectiveFerracini, M. / Nakada, C. P. et al. | 2013
- A335
-
A Systematic Review of Patient Preferences for Subcutaneous MedicationsRidyard, C. / Dawoud, D. / Hughes, D. A. et al. | 2013
- A336
-
Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly: A Discrete Choice StudyShiroiwa, T. / Saito, S. / Shimozuma, K. / Kodama, S. / Noto, S. / Fukuda, T. et al. | 2013
- A338
-
Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, BrazilFerraz, M. B. / Nardi, E. P. et al. | 2013
- A339
-
Health Outcomes of Female Anabolic-Androgenic Steroid UsersNoone, J. / Blanchette, C. M. et al. | 2013
- A340
-
The Geographic Correlation Between Lyme Disease Incidence and Degenerative Neurological Disease Mortality: An Ecological StudyVeley, K. M. / Malka, E. S. et al. | 2013
- A341
-
Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter TrialStahmeyer, J. T. / Rossol, S. / Bert, F. / Abdelfattah, A. M. / Mauss, S. / Heyne, R. / John, C. / Pape, S. / Schober, A. / Teuber, G. et al. | 2013
- A342
-
Burden of Varicella in Eastern Europe: A Systematic Review and Critical AnalysisYang, H. K. / Song, K. M. / Manoff, S. / Liaw, K. L. / Kuter, B. et al. | 2013
- A343
-
Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United StatesBrogan, A. / Talbird, S. E. / Thompson, J. R. / Kim, Y. A. / Olson, J. / Peterson, J. / Piontkowsky, D. / Pietrandoni, G. et al. | 2013
- A344
-
Examining the Relationship Between Country-Level Factors and Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and UgandaYang, W. / Parisi, M. / Lahue, B. J. / Bishai, D. M. et al. | 2013
- A345
-
Pharmacoeconomic Evaluation of the Fixed-Dose Combination of Abacavir/Lamivudine in the Antiretroviral Therapy of Naïve HIV Infected Patients in RussiaPyadushkina, E. / Omelyanovsky, V. / Avxentyeva, M. / Rebrova, O. / Andreeva, N. et al. | 2013
- A346
-
Counting the Cost of Meningococcal Disease in FranceFaivre, P. / Bénard, S. / Wright, C. / Voisine, J. / Gaudelus, J. et al. | 2013
- A347
-
Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from RussiaAvxentev, N. / Avxentyeva, M. / Platonov, A. / Kolyasnikova, N. / Gridneva, K. / Dolgin, V. / Titkov, A. / Derkach, E. V. et al. | 2013
- A348
-
The Association Between Adherence to Antiretroviral Therapy and Economic Outcomes Among Commercially Insured and Medicaid HIV Patients in the United StatesKorsnes, J. S. / Goodwin, B. / Candrilli, S. D. et al. | 2013
- A349
-
Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, CanadaLachaine, J. / Vachon, M. L. / Lambert-Obry, V. / Beauchemin, C. et al. | 2013
- A350
-
When Treatment Is Mitigated by Adverse Events: The Economic Impact of Treatment-Associated Adverse Events in Cirrhotic Non-Responders Treated with Boceprevir or Telaprevir and Peginterferon Alpha/RibavirinSullivan, S. / McDermott, C. / Dieterich, D. / Martel-Laferriere, V. / Saab, S. / Gordon, S. et al. | 2013
- A351
-
Cost-Effectiveness Analysis of 3 Candins and Fluconazole in the Treatment of Confirmed Invasive Candidiasis in Adult Non-Neutropaenic Patients in SpainGrau, S. / Pozo, J. C. / Roma, E. / Salavert, M. / Collados, C. / Egea-GarcÃa, M. / Mesa, F. J. / Llevat, N. / Barrueta, A. et al. | 2013
- A352
-
Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization ProgramTichopad, A. / Vitova, V. / Roberts, C. S. / Hájek, P. et al. | 2013
- A353
-
A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Costa RicaGarita, M. / Solano, A. / Cuesta, G. / Mould, J. et al. | 2013
- A355
-
Different Discounting Approaches and Their Impact in Economic Evaluation: A Practical Example Using Hepatitis B VaccinationCure, S. / Bianic, F. / Nandini Kahol, D. / Davie, A. et al. | 2013
- A356
-
Economic Analysis of Protease Inhibitors in First-Line Haart in Adult Patients with HIVAvxentyeva, M. / Goryaynov, S. / Rebrova, O. et al. | 2013
- A358
-
Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in RussiaPyadushkina, E. / Omelyanovsky, V. / Avxentyeva, M. / Rebrova, O. / Goryaynov, S. et al. | 2013
- A359
-
COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLANDKaczor, M. P. / Wójcik, R. / Pawlik, D. / Skrzekowska-Baran, I. / Tronczynski, K. et al. | 2013
- A361
-
Patient Satisfaction with HIV Therapies: Focus on Adherence to TreatmentMurray, M. / Dang, N. / Swinburn, P. / Gallop, K. / Lloyd, A. et al. | 2013
- A362
-
Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)Baran, R. W. / Anderson, R. T. / Dietz, B. / Gooch, K. et al. | 2013
- A364
-
United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus MedicationsHogue, S. / Brogan, A. / Goodwin, B. et al. | 2013
- A365
-
Clinical Guidelines Evidence as a Criterion for Changes in the Legislation Combating TuberculosisStepanenko, A. / Lishchyshyna, O. / Melnyk, Y. et al. | 2013
- A366
-
RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)Paes, B. A. / Li, A. / Mitchell, I. / Lanctot, K. L. et al. | 2013
- A367
-
Estimation of the Number of Cases of Nosocomial Pneumonia in Adults Caused by Gram-Positive Bacteria in Public Hospitals in MexicoGryzbowski, E. / Peniche-Otero, G. / Herrera-Rojas, J. / Bolaños-Cornejo, D. / Huicochea-Bartelt, J. L. / Muciño-Ortega, E. et al. | 2013
- A368
-
The Influence of Improved Adherence and Persistence in Chronic Obstructive Pulmonary Disease (COPD) Costs: Systematic Review of the LiteraturePérez, M. / Dominguez, J. / Armengol, S. / Paz, S. / Lizán, L. et al. | 2013
- A369
-
Impact of Chronic Pain on Health Care Costs in Chronic Obstructive Pulmonary Disease as Compared to Other Chronic DiseasesMapel, D. / Roberts, M. / Von Worley, A. et al. | 2013
- A370
-
Predicting Health Care Costs in Asthma Using the EQ-5D Index ScoreGu, N. Y. / Raisch, D. W. / Wu, J. / Gai, Y. / Hay, J. W. et al. | 2013
- A371
-
Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal PerspectiveCosta-Scharplatz, M. / Tambour, M. / Henriksson, F. / Ställberg, B. et al. | 2013
- A372
-
Empirical Therapy for Respiratory Tract Infections in an Era of Increasing Antimicrobial Resistance: A Decision and Cost AnalysisBabela, R. et al. | 2013
- A373
-
Factors Related to Adherence After a Multifactorial Intervention to Improve It in Patients with Chronic Obstructive Pulmonary Disease (COPD). Icepoc StudyLeiva-Fernandez, F. / Leiva-Fernandez, J. / Prados-Torres, D. / GarcÃa-Ruiz, A. J. / Barnestein-Fonseca, P. et al. | 2013
- A374
-
Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United StatesCaron, M. / Perrier, L. L. / Acquadro, C. et al. | 2013
- A375
-
The Rand Negative Impact of Asthma on Quality of Life Item Bank and Short-FormsSherbourne, C. / Stucky, B. / Edelen, M. O. / Eberhart, N. / Lara, M. et al. | 2013
- A376
-
Patterns in Asthma Medicationtreatment in the United StatesLi, Y. / Suh, K. / Chen, W. / Wei, Z. / Higuchi, K. et al. | 2013
- A377
-
Clinical Effectiveness Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood TransfusionsWalczak, J. / Lipińska, M. / Jarosz, J. / Moczyński, W. / Ślązak, B. / Laczewski, T. et al. | 2013
- A378
-
Budget Impact Analysis of Deferasirox in the Treatment of Non Transfusion Dependent Thalassemia in GreeceMasoura, P. / Murphy, D. R. / Chatzikou, M. / Alexopoulos, S. T. / Magestro, M. et al. | 2013
- A379
-
Pharmacoeconomic Evaluation of Intravenous Ferric Carboxymaltose and Iron Sucrose in Correction of Preoperative Anaemia in Patients Undergoing Major Elective SurgeryGorokhova, S. G. / Ryazhenov, V. V. / Emchenko, I. V. et al. | 2013
- A380
-
Haemophilia A: Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in France: We Should Compare the Cost Per Patient Instead of the Price Per UnitHaarmann, H. / Epstein, J. / Grumel, O. et al. | 2013
- A381
-
A Systematic Literature Review on the Epidemiology and Economic Burden of Anaemia Associated with Chronic Kidney DiseaseRizzo, M. / Iheanacho, I. / van Nooten, F. E. / Goldsmith, D. et al. | 2013
- A382
-
Cost-Consequence Analysis of a Treatment Strategy Including Ponatinib Compared to a Treatment Strategy Including Only the 2nd Generation Tyrosine Kinase Inhibitors (2g TKIs), Dasatinib or Nilotinib, in Resistant Patients with Philadelphia Chromosome-Positive (Ph+) Leukemia, in ItalyChiroli, S. / Furneri, G. / Pane, F. et al. | 2013
- A383
-
The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an AnalgesicCawson, M. / Knight, C. / Hirst, M. / Dunlop, W. et al. | 2013
- A384
-
Cost-Effectiveness of Plerixafor (PXF) for Stem Cell Mobilization in Lymphoma (NHL/HL) and Multiple Myeloma (MM) Patients in PolandKaczor, M. P. / Wójcik, R. / Pawlik, D. / Glasek, M. / Pieczonka, A. / Lis, J. et al. | 2013
- A385
-
Full Cost of Plasma from Voluntary Non Remunerated Donors in ItalyZaniolo, O. / Povero, M. / Gandini, G. / Aprili, G. / Eandi, M. et al. | 2013
- A386
-
The Use of Preference Based Measures in Haemophilia: Is the Current Evidence Base Useful for Evidence Based Decision Making?Tolley, K. / Miners, A. / Brazier, J. / Pericleous, L. M. / Sharma, T. / Petersen, J. / Lonergan, T. et al. | 2013
- A387
-
The Impact of Increasing Pain Severity on Impairment of Regular Daily ActivitiesPoole, C. D. / Chambers, C. / Odeyemi, I. / Currie, C. et al. | 2013
- A388
-
Likelihood of Use and Perception Towards Biosimilars in Rheumatoid Arthritis Arena: Survey of Rheumatologists in European Union, Brazil, Japan and ChinaNarayanan, S. / Liu, L. et al. | 2013
- A389
-
Appetite Suppressants: A Drug Utilisation StudyTruter, I. et al. | 2013
- A390
-
Cost-Minimization of Mabthera Intravenous Versus Subcutaneous AdministrationBax, P. / Postma, M. J. et al. | 2013
- A392
-
Evaluation of the Burden of Illness of Colorectal Cancer Among Veteran Patients in the United StatesWang, L. / Xie, L. / Li, L. / Wang, Y. / Kariburyo, M. F. / Baser, O. et al. | 2013
- A393
-
An Indirect Treatment Comparison of the Efficacy of Everolimus (Afinitor®) and Fulvestrant for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast CancerChandiwana, D. / Vieira, J. / Granville, J. / McCool, R. / Fleetwood, K. et al. | 2013
- A394
-
A Mixed Treatment Comparison (MTC) to Compare Progression Free Survival (PFS) Associated with Different Chemotherapy Regimens for Platinum-Sensitive or Partially Platinum-Sensitive Recurrent Advanced Ovarian CancerEdwards, S. J. / Barton, S. / Thurgar, E. / Wakefield, V. / Karner, C. / Trevor, N. et al. | 2013
- A395
-
Second-Line Treatment of Metastatic Colorectal Cancer (mCRC): A Systematic Literature Review (SLR) and Feasibility Assessment of Conducting Indirect Treatment Comparison (ITC) AnalysisXu, Y. / Martin, A. L. / Ross, S. / Knopf, K. B. / Strand, L. / Iqbal, S. U. / Joulain, F. / Jasso Mosqueda, J. G. / Fahrbach, K. et al. | 2013
- A396
-
Off-Label Trastuzumab Usage in Breast Cancer Patient in TurkeyKockaya, G. / Tanyeri, P. / Buyukokuroglu, M. E. / Yenilmez, F. B. / Durmus, D. / Vural, I. M. / Akbulat, A. / Artiran, G. / Gursoz, H. / Kerman, S. et al. | 2013
- A397
-
Aflibercept + FOLFIRI (AF) Versus. Placebo + FOLFIRI (PF) in Metastatic Colorectal Cancer (mCRC): Mean Overall Survival (OS) in a “Better Responders†Patient Population of the Velour TrialJoulain, F. / Naoshy, S. / Chau, I. / Iqbal, S. U. / Bridgewater, J. et al. | 2013
- A398
-
Economic Impact of Denosumab for Skeletal Related Event Prevention in Patients with Prostate Cancer and Bone Metastasis from a United State Managed Care Organization PerspectiveArellano, J. / Cristino, J. / Chen, K. et al. | 2013
- A399
-
Breast Cancer Screening Program in the Basque Country: Costs and Health Benefits Assessment Through Discrete Event SimulationArrospide, A. / Mar, J. / Comas, M. / Rue, M. / Larrañaga, N. / Acaiturri, T. / Sarriugarte, G. et al. | 2013
- A400
-
Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic LeukemiaWalzer, S. / Tournier, C. / Marino, J. P. / Mueller, E. / Duong, M. et al. | 2013
- A401
-
Cost of Adverse Events During Treatment with Everolimus Plus Exemestane or Single-Agent Chemotherapy in Patients with Advanced Breast CancerCampone, M. / Yang, H. / Faust, E. / Kageleiry, A. / Signorovitch, J. / Zhang, J. / Gao, H. et al. | 2013
- A402
-
Costs of Pilot Programs Employing Allied Health Professionals Within the Centers for Population Health and Health DisparitiesWalton, S. / Johnson, T. J. / Li, C. C. / Joyce, B. et al. | 2013
- A403
-
The Humanistic and Economic Burden of Venous Thromboembolism in Cancer Patients: A Systematic ReviewKourlaba, G. / Relakis, J. / Kontodimas, S. / Holm, M. V. / Maniadakis, N. et al. | 2013
- A404
-
Estimating the Cost of HPV-Related Diseases in Turkey: A Delphi ApproachBakir, M. / Ayhan, A. / Arvas, M. / Kose, M. F. / Gungor, M. / Ortac, F. / Ozgul, N. / Yuce, K. / Ergun, T. / Gungor, E. et al. | 2013
- A405
-
Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in France, Italy, the Netherlands, and SpainBilir, S. P. / Zhao, Z. / Wehler, E. A. / Munakata, J. / Barber, B. et al. | 2013
- A407
-
Estimation of the Epidemiological and Economic Impact of the Quadrivalent HPV Vaccination in Girls and Boys in SpainBosch, X. / Cortés Bordoy, J. / Gil de Miguel, A. / López Belmonte, J. L. / Bresse, X. / Serip, S. / Nieves, D. et al. | 2013
- A408
-
Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder CancerMarteau, F. / Kornowski, A. / Bennison, C. / Tempest, M. J. / Mariappan, P. / Witjes, J. A. et al. | 2013
- A409
-
Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germanyvan Beurden-Tan, C. / Rosiñol, L. / Diels, J. / Wirth, D. / Chirita, O. / Lahuerta, J. J. / Gaugris, S. / Marsh, S. / San Miguel, J. / Spencer, M. et al. | 2013
- A410
-
Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple MyelomaRochau, U. / Jahn, B. / Qerimi, V. / Kluibenschaedl, M. / Kurzthaler, C. / Conrads-Frank, A. / Willenbacher, W. / Gastl, G. / Siebert, U. et al. | 2013
- A411
-
A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian JurisdictionBerghea, F. / Skoupa, J. / Ciuleanu, T. / Miron, L. / Stanculeanu, D. L. / Jinga, D. / Dediu, M. / Mateescu, D. N. / Hájek, P. / Bradatan, B. et al. | 2013
- A413
-
Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated with Highly and Moderately Emetogenic Cancer Chemotherapy in RussiaKrysanov, I. / Krysanova, V. et al. | 2013
- A414
-
Cost-Effectiveness of First-Line Treatment of Advanced Metastatic Non Small Cell Lung Cancer- A Systematic Review of Economic ModelsEijgelshoven, I. / Verduyn, S. C. / Bhatti, T. / Bexelius, C. / Jansen, J. P. et al. | 2013
- A415
-
Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in JapanShibahara, H. / Shiroiwa, T. / Nakamura, K. / Shimozuma, K. et al. | 2013
- A416
-
Head to Head Economic Evaluation of Two Genomic Profiles of Recurrence Risk for Breast Cancer, Mammaprint Versus Oncotype DX, in SpainCrespo, C. / SeguÃ, M. / Cortés, J. / Lluch, A. / Brosa, M. / Becerra, V. / Chiavenna, S. M. / Gracia, A. et al. | 2013
- A417
-
Economic Activity of Cancer Survivors in PolandMacioch, T. / Hermanowski, T. R. et al. | 2013
- A418
-
Persistence in Patients with Breast Cancer Treated with Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer DatabaseSchmidt, N. / Haas, G. / Mergenthaler, U. / Kostev, K. / Hadji, P. et al. | 2013
- A420
-
Systematic Review of Patient Reported Outcomes in Chronic Myeloid LeukemiaAggarwal, S. / Segal, J. / Topaloglu, H. et al. | 2013
- A421
-
Influence of Anxiety and Depression on 1-Year Health Related Quality of Life in Colorectal Cancer PatientsEscobar, A. / Billbao, A. / Trancho, Z. / Quintana, J. / Sarasqueta, C. / Baré, M. et al. | 2013
- A422
-
HR-QOL Data in the Amnog Early Benefit Assessment: Industry and IQWIG/GBA PerspectiveObradovic, M. / Radicek, S. / Rauland, M. et al. | 2013
- A424
-
Are ICER Threshold Values Malleable? The Case of Life-Extending Cancer Treatments at the End of LifeMoïse, P. / Sweeney, N. / Lie, X. et al. | 2013
- A425
-
A Disease Model of Metastatic Colorectal Cancer Including Multiple Treatment Linesvan Rooijen, E. M. / Uyl-de Groot, C. A. / Punt, C. / Koopman, M. / Coupe, V. M. et al. | 2013
- A427
-
A Novel Algorithm Using Claims Data to Identify Patients with Castration-Resistant Prostate Cancer (CRPC)Gorritz, M. / Thompson, S. F. / Lee, Y. C. / Stern, L. / Penson, D. F. et al. | 2013
- A428
-
Impact of Recommended Pharmaceuticals on Cancer Mortality: Analysis of Real-Life DataWilson, T. / Hamerslag, L. et al. | 2013
- A429
-
Economical Losses Due to Disablementparents Carring for Children with Oncohematological DiseasesGanieva, D. / Zhukovskaya, E. / Spichak, I. et al. | 2013
- A432
-
A Bayesian Multiple Treatment Comparison of Duloxetine, Pregabalin, Gabapentin, Amitriptyline, and Their Combinations for Painful Peripheral Neuropathy Based on Pain Reduction Reported in Clinical TrailsChinthammit, C. / Malone, D. et al. | 2013
- A433
-
The Presence of Metabolic and Other Risk Factors in Adrenal Insufficiency Patients Compared to an Unmatched Background Population from the Same Region in the United KingdomTeneishvili, M. / Marelli, C. / Lee, D. et al. | 2013
- A434
-
Early Life Determinants of Metabolic Syndrome and Diabetes Mellitus in South Asian Population Living in Europe: A Systematic ReviewCallejo, D. / DÃaz-Cuervo, H. / Cuervo, J. / Rebollo, P. / Hussain, A. / Hitman, G. A. et al. | 2013
- A436
-
Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with InsulinFoos, V. / Grant, D. / Palmer, J. L. / Varol, N. / Curtis, B. / Boye, K. S. / McEwan, P. et al. | 2013
- A437
-
First Russian Type 2 Diabetes Mellitus Simulation Model with Discrete Events Modeling. Health-Economic AnalysisKolbin, A. / Kurylev, A. / Balykina, Y. / Proskurin, M. et al. | 2013
- A439
-
Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Type 1 Diabetes in Kazakhstan ChildrenRoze, S. / Demessinov, A. / Zeityn, M. / Toktarova, N. / Abduakhassova, G. / Sissemaliev, R. / Karamalis, M. / Dunne, N. / Muratalina, A. / Klots, M. et al. | 2013
- A440
-
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK SettingWillis, M. / Johansen, P. / Schroeder, M. / Thompson, G. / Girod, I. / Neslusan, C. et al. | 2013
- A441
-
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK SettingGirod, I. / Willis, M. / Johansen, P. / Schroeder, M. / Thompson, G. / Neslusan, C. et al. | 2013
- A442
-
The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in BelgiumJugrin, A. V. / Lamotte, M. / Malfait, M. / Vandebrouck, T. et al. | 2013
- A443
-
Review of Cost of Diabetes Complications in Four European CountriesBeaudet, A. / Grabbi, E. / Maurel, F. / Ramos, M. / Lebioda, A. et al. | 2013
- A444
-
Do Fixed-Dose Combinations Improve Antidiabetic Treatment Compliance? A Study Based on French IMS Lifelink Disease Analyzer DatabaseGrandfils, N. / Le Jeunne, P. / Maillard, C. / Solomiac, A. / Besson, A. et al. | 2013
- A445
-
Health-Related Quality of Life and Utility in Patients with Diabetic Foot Syndrome - An EQ-5D Survey in PolandSobol, E. / Macioch, T. / Krakowiecki, A. / Mrozikiewicz-Rakowska, B. / Mienicka, A. / Mlynarczuk, M. / Kasprowicz, M. / Paweska, J. / Karnafel, W. / Hermanowski, T. R. et al. | 2013
- A446
-
Assessing Quality of Life in Adult Growth Hormone Deficiency: Further Development of the QoL-AGHDAGraham, J. E. / McKenna, S. / Wilburn, J. / Twiss, J. et al. | 2013
- A448
-
Impact of Nocturnal and Daytime Non-Severe Hypoglycaemic Events on People with Diabetes in South AfricaSnyman, J. / Todorova, L. et al. | 2013
- A449
-
The Impact of Memory Problems on Diabetes Treatment in GermanyBrod, M. / Kongso, J. / Bushnell, D. M. et al. | 2013
- A451
-
Real Life Applications of Social Security Institution (SSI) Regulations; A Case Study of DPP4 Inhibitors in Treatment of Diabetes in Turkish Health Care SystemKececioglu, S. / Ulus, P. / Cukadar, F. / Ozkan, M. / Urganci, B. et al. | 2013
- A453
-
How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?Deger, C. C. / Tuna, E. / Ozdemir, Z. / Ozel, M. O. / Parali, E. / Sumer, F. / Yilmaz, Z. S. et al. | 2013
- A455
-
Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy CandidatesLabban, M. / Izmirlieva, M. / Ando, G. et al. | 2013
- A456
-
2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDSDehnen, J. / Schmoeller, M. et al. | 2013
- A457
-
Pricing of “Follow-On†Drugs and Competition Within Pharmaceutical Classes: Evidence from Germany 1993-2008Mueller, M. T. / Frenzel, A. et al. | 2013
- A458
-
Constructing an Index of International Pharmaceutical Prices. A Comparison of Pharmaceutical Prices in 56 CountriesDavey, P. et al. | 2013
- A459
-
EU Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement DecisionsHogue, S. / Hollis, K. / McLeod, L. / Brogan, A. / Heyes, A. E. et al. | 2013
- A460
-
How Does Prescription of Generic Drugs Spread Out?: Data Mining and Visualization by Using Prescription Data Form Acute Care Hospitals NationwideShimizu, S. / Ishikawa, K. B. / Ikeda, S. / Fushimi, K. et al. | 2013
- A461
-
A Systematic Evaluation of Drug-Drug Interactions in Prescriptions; Facts and ComparisonsAhmad, M. / Arshad, W. / Usman Minhas, M. et al. | 2013
- A462
-
Current Status and Evidence of Effects of E-Prescribing Implementation in United Kingdom, Italy, Germany, Denmark, Poland and United StatesHermanowski, T. R. / Kowalczyk, M. / Szafraniec-Burylo, S. I. / Krancberg, A. N. / Pashos, C. L. et al. | 2013
- A463
-
Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in HungaryCs. Horváth, Z. / Molics, B. / �goston, I. / Sebestyén, A. / Boncz, I. et al. | 2013
- A464
-
Variability in Publically-Prescribed Drug Costs: The Role of Region, Age and GenderO Céilleachair, A. J. / Woods, N. / O’Sullivan, K. / Kenneally, M. et al. | 2013
- A465
-
Cost-Effectiveness of an Interface Geriatric Intervention: Acute Medical Unit Comprehensive Geriatric Assessment Intervention Study (AMIGOS)Tanajewski, L. / Franklin, M. / Gkountouras, G. / Berdunov, V. / Edmans, J. / Conroy, S. / Bradshaw, L. / Gladman, J. / Elliott, R. A. et al. | 2013
- A466
-
Pharmaceutical Expenditure, Clinical Outcomes and Expenditures on Other Health ServicesSiskou, O. / Galanis, P. / Tsavalias, K. / Kalogeropoulou, M. / Kaitelidou, D. / Pasaloglou, S. / Schneider, M. / Liaropoulos, L. et al. | 2013
- A468
-
Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in SerbiaMedic, G. / Baltezarevic, D. / Novakovic, T. et al. | 2013
- A469
-
Acceptability of Indirect Evidence to Support Drug Reimbursement in AustraliaO’Leary, B. A. / McKenna, S. J. / Cheng, Y. Y. / McElroy, H. J. et al. | 2013
- A471
-
Investigating Safety-Appraoch in Saudi Arabia Ministry of Health HospitalsAlkelya, M. A. / Haleem, R. M. et al. | 2013
- A472
-
Confidential Patient Access Schemes in the United Kingdom – Do They Affect Prices in Other Markets?Nijhuis, T. / Haigh, J. / Van Engen, A. et al. | 2013
- A473
-
A Systematic Comparison of Market Access and Reimbursement Pathways for Diagnostic Tests in Germany, United Kingdom and the United StatesWalzer, S. / Gartemann, J. et al. | 2013
- A474
-
Pricing and Reimbursment of Pharmaceuticals in IranMoradi, M. et al. | 2013
- A475
-
A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)Charokopou, M. / Heeg, B. / Schoeman, O. / Mueller, S. / Tempest, M. J. / Schlagmüller, S. C. / Wilke, T. et al. | 2013
- A476
-
Point of Care Tests: The Long and Winding Road to ReimbursementHogue, S. / Brogan, A. / Heyes, A. et al. | 2013
- A478
-
Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies from 2000 to 2012 in TurkeyKockaya, G. / Daylan Kockaya, P. / Ergin, G. et al. | 2013
- A479
-
Workshop in Pharmacoeconomics: An Italian Experience of Multi-Stakeholder Hta ConsensusCicchetti, A. / Gasbarrini, A. / Ruggeri, M. / Sacchini, D. / Lanati, E. P. et al. | 2013
- A480
-
Key Drivers of Pbac Decisions for the Reimbursement of Orphan Drugs on the Life Saving Drugs ProgramMaguire, B. / Tilden, D. et al. | 2013
- A481
-
Analysis of Transparency Amongst International Health Technology Assessment OrganizationsJebrail, F. / Duong, M. / Shum, D. et al. | 2013
- A482
-
Which Should Be the Correct NMA to Be Used? A Review of HTA RecommendationsSolozabal, M. / Roset, M. / Rojas-Farreras, S. / González-Rojas, N. / Gil, A. et al. | 2013
- A483
-
Number of Submissions Needed to Reach a Positive Reimbursement Decision from SMC, CADTH, and PBACJaksa, A. / Ho, Y. S. / Daniel, K. et al. | 2013
- A484
-
Relevance of Indirect Comparisons in the German Early Benefit Assessment (AMNOG)Lebioda, A. / Gasche, D. / Dippel, F. W. / Plantör, S. et al. | 2013
- A485
-
Systematic Review on Use of Economic Evidence by Clinical GuidelinesAggarwal, S. / McGrane, M. / Topaloglu, H. et al. | 2013
- A486
-
Guidance for Partnership Working Between CatSalut and the Pharmaceutical IndustryGilabert, A. / Espinosa, C. / Mora, R. / Santos, J. et al. | 2013
- A487
-
Coverage with Evidence Development in Sweden – Formality or Effective Way to Reduce Uncertainty?Kornfeld, A. / Schroeder, M. / Toumi, M. et al. | 2013
- A489
-
The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)Wahlster, P. / Niederländer, C. S. / Kriza, C. / Kolominsky-Rabas, P. L. et al. | 2013
- A490
-
How Do Oncology Drug Prices Vary Across EU5, the United States, and Bric Markets?Patel, P. / Donze, B. / Zaganelli, D. et al. | 2013
- A491
-
Review of Economic Principles of Branded “Me-Too†Drugs MarketHren, R. et al. | 2013
- A492
-
Understanding the Effect of Clostridium Difficile Infection on Hospital Mortality in England, the Netherlands, and SpainWasserman, M. / Jones, C. / Roberts, G. / Latif, F. et al. | 2013
- A494
-
Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in ItalyLa Torre, G. / Miele, L. / Mannocci, A. / Saulle, R. / Giraldi, G. / Unim, B. / Ursillo, P. / Semyonov, L. / Colamesta, V. / Melcarne, R. et al. | 2013
- A495
-
Utilisation and Costs of Inpatient and Outpatient Services Among Patients with Irritable Bowel Syndrome- A Study Using the Clinical Practice Research Datalink (CPRD)Murray-Thomas, T. / Dedman, D. / Canavan, C. / West, J. / Card, T. et al. | 2013
- A496
-
An Economic Evaluation Comparing ePTFE Covered Stent-Grafts Configured for Tips with Bare Metal Stents in Procedures for the Treatment of Portal Hypertension ComplicationsBurke, M. / Hacking, N. / Wright, M. / Iqbal, K. / Craig, J. et al. | 2013
- A497
-
Crohn’s Disease: An Economic Assessment of Biological Drugs in ItalyCicchetti, A. / Gasbarrini, A. / Ruggeri, M. et al. | 2013
- A499
-
Validation of the Crohn’s Life Impact Questionnaire (CLIQ), the First Patient-Reported Outcome Measure Specific to Adults with Crohn’s DiseaseWilburn, J. / McKenna, S. / Twiss, J. / Kemp, K. / Campbell, S. et al. | 2013
- A500
-
Systematic Literature Review in Moderate to Severe Ulcerative ColitisHuisman, E. / Medic, G. / Eijgelshoven, I. / Weijers, L. / Karabis, A. et al. | 2013
- A501
-
Indirect Comparison of the Effect of Biologics in Patients with Psoriasis; A Meta-Analysis of Randomized, Double Blind Clinical Trials in Bayesian FrameworkBrodszky, V. / Mo, M. / Gulacsi, L. / Baji, P. / Balogh, O. / Péntek, M. et al. | 2013
- A502
-
Children with Atopic Dermatitis: Monitoring a French Cohort Over a Nine-Year PeriodTaieb, C. et al. | 2013
- A503
-
Spectacle Independence and Vision-Related Quality of Life in Cataract Surgery Patients Following Implantation of a Multifocal Intraocular LensSamiian, A. / Carones, F. et al. | 2013
- A504
-
Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriasis in the United StatesTencer, T. / Li, S. / Zhang, F. et al. | 2013
- A505
-
Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in the United KingdomBetts, K. A. / Sundaram, M. / Mughal, F. / Yan, S. Y. / Signorovitch, J. / Wang, K. / Wu, E. Q. et al. | 2013
- A506
-
The Cost-Effectiveness of Bimatoprost 0.03%/Timolol 0.05% Preservative-Free Fixed Combination Compared with Dorzolamide/Timolol Preservative-Free Fixed Combination and 2-Bottle Unfixed Combinations for the Treatment of Primary Open-Angle Glaucoma in the United KingdomHirst, A. / Almond, C. / Brereton, N. J. / Shergill, S. / Wong, W. et al. | 2013
- A507
-
Cost-Effectiveness of Sequences of Biologic Treatments for Moderate-To-Severe Psoriasis in FinlandAsseburg, C. / Valgardsson, S. / Soini, E. J. et al. | 2013
- A508
-
The Burden Imposed by Atopic Dermatitis on Families: Creation of a Specific QuestionnaireTaieb, C. / Branchoux, S. et al. | 2013
- A509
-
Quality of Life of Patients Suffering from Exudative Age-Related Macular Degeneration and Treated by Intravitreal Injections and Its Predictors: The Equade StudyLeveziel, N. / Joubert, M. / Hermans, M. / Moser, E. / Le Picard, S. / Maurel, F. et al. | 2013
- A511
-
Adherence by Spanish Retinologists to the Guidance for the Management of Patients with Wet Age-Related Macular DegenerationColomé, A. / Balaña, M. / Ruiz Moreno, J. M. / Roura, M. et al. | 2013
- A512
-
High Dosages of Statins in High Cardiovascular Risk Patients in a Real World Setting: Treatment Patterns and OutcomesDegli Esposti, L. / Sangiorgi, D. / Buda, S. et al. | 2013
- A513
-
Venous Thromboembolism in Gynae-Oncology Patients Post Surgery – Is Tinzaparin Prophylaxis an Effective Anticoagulant?Ibrahim, N. / Norris, L. / O’Toole, S. / Gleeson, N. et al. | 2013
- A514
-
Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: A Systematic Literature ReviewClaflin, A. B. / Liu, X. / Phatak, H. et al. | 2013
- A515
-
Anticoagulant Use in Hospitalized Patients with Acute Venous Thromboembolism in the United StatesLiu, X. / Xie, L. / Phatak, H. / Mardekian, J. / Tan, W. / Baser, O. / Schneider, R. F. / Ramacciotti, E. et al. | 2013
- A518
-
A Budget Impact Analysis to Estimate the Economic Impact of Drug Eluting Balloon for the Treatment of Peripheral Vascular DiseaseCorbo, M. / Beccagutti, G. / Manda, B. et al. | 2013
- A519
-
Pharmacoeconomic Benefits of Citicoline in the Treatment of Acute Ischemic Stroke in RussiaRyazhenov, V. V. / Gorokhova, S. G. et al. | 2013
- A520
-
The Burden of Resistant Hypertension in 5 European CountriesSapoval, M. / Hale, B. C. / Armstrong, S. / Da Deppo, L. / Hertz, D. / Briggs, A. et al. | 2013
- A521
-
Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)Berger, A. / LaPensee, K. / Oster, G. et al. | 2013
- A523
-
Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis TreatmentsSmolen, H. J. et al. | 2013
- A524
-
Cost-Effectiveness of Apixaban Versus Standard of Care for the Prevention of Stroke: An Analysis of Patients with Atrial Fibrillation in GreeceAthanasakis, K. / Arzoumanidou, D. / Karampli, E. / Armelidou, E. / Giovas, P. / Petrikkou, E. / Kyriopoulos, J. et al. | 2013
- A525
-
Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in ItalyCapri, S. / Veneziano, M. / Ricciardi, W. G. / D’Ausilio, A. / Pedone, M. P. / Bianchi, C. et al. | 2013
- A526
-
The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in AustraliaTilden, D. / Germanos, P. / Gordon, J. / Tocchini, L. et al. | 2013
- A527
-
The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in BelgiumJugrin, A. V. / Caekelbergh, K. / Vanacker, J. / Vancauwenberghe, L. / Lamotte, M. et al. | 2013
- A528
-
Cost-Effectiveness Analysis of Ivabradine in Chronic Heart Failure in the Polish SettingBorowiec, L. / Faluta, T. / Filipiak, K. J. / Niewada, M. / Wrona, W. et al. | 2013
- A529
-
Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the NetherlandsStevanovic, J. / Pompen, M. / Le, H. H. / Rozenbaum, M. H. / Postma, M. J. et al. | 2013
- A530
-
Cost-Utility Analysis of Coronary Artery Calcium Score to Guide Statin Therapy in Patients with Elevated C-Reactive Protein and Low LDL Cholesterol LevelsSilva Miguel, L. / Ferreira, A. M. et al. | 2013
- A531
-
Real World Resource Use Associated with Transcatheter Aortic Valve Implantation and Conventional Aortic Valve Replacement SurgeryAwad, W. / Mathur, A. / Baldock, L. / Oliver, S. / Kennon, S. et al. | 2013
- A532
-
Effects of the Occurrence of a First Cardiovascular Event on Statin Adherence in Type 2 Diabetes: A Matched Cohort Designde Vries, F. M. / Denig, P. / Vegter, S. / Bos, H. J. / Postma, M. J. / Hak, E. et al. | 2013
- A533
-
The Relation Between the Modified Rankin Scale (mRS) Scores and Utility Weights: Results from a Survey Among Community Dwelling Long Term Stroke SurvivorsGreenberg, D. / Ginsberg, G. / Ziv, A. / Litmanovitch-Goldstein, D. / Tanne, D. / Chodick, G. / Balicer, R. D. / Dankner, R. et al. | 2013
- A534
-
A Retrospective Study Comparing Compliance, Persistence, and Blood Pressure Control Between Free-Drug and Single-Pill Combination Therapies in Korean Hypertensive PatientsHong, J. M. / Kim, E. G. / Min, K. / Min, J. / Shin, K. / Yang, B. M. et al. | 2013
- A535
-
Coronary Artery Disease, Diabetes, and Health-Related Quality of Life: Findings of a Cohort Study from IndiaShah, B. S. / Deshpande, S. S. et al. | 2013
- A536
-
Adherence to Warfarin Treatment in Brazil: Systematic Review of the LiteratureFeijo, L. F. / Clark, O. A. / Monteiro, R. C. / Fujii, R. K. / Donato, B. M. / Bernardino, G. D. / Barbieri, D. E. / Mould, J. / Manfrin, D. F. et al. | 2013
- A537
-
Cross-Country Comparison of Prescribing Patterns Versus Portugal and Potential Cost-SavingsCosta, S. / Guerreiro, J. P. / Baptista, A. / Teixeira, I. / Torre, C. et al. | 2013
- A538
-
Analysis of Re-Hospitalisations for Stroke and Transient Ischemia Recurrence and Associated Costs in the Burgundy Region in FranceMarty, R. / Jouaneton, B. / Giroud, M. / Mougin, P. / Roze, S. et al. | 2013
- A539
-
The Volume-Outcome Relationship and Minimum Volume Standards – Empirical Evidence for GermanyMennicken, R. / Hentschker, C. et al. | 2013
- A540
-
Divergence of HTA Decisions Across Countries: Case Analysis of IvabradineThivolet, M. / Rémuzat, C. / Kornfeld, A. / Toumi, M. et al. | 2013
- A541
-
Results from the “Autor†Study, a European Observational Study in Pediatric Patients with Attention-Deficit/Hyperactivity DisorderHaynes, V. / Lopez-Romero, P. / Anand, H. et al. | 2013
- A542
-
Comparative Efficacy and Metabolic Side Effects of Lurasidone for the Management of Acute Schizophrenia: A Systematic Literature Review and Mixed Treatment Comparison with First and Second Generation AntipsychoticsGuelfucci, F. / Watt, M. / Vimont, A. / Roïz, J. / Cadi-Soussi, N. et al. | 2013
- A543
-
Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform StudySaragoussi, D. / Haro, J. M. / Boulenger, J. P. / Jönsson, B. / Knapp, M. / Caillou, H. / Chalem, Y. / Milea, D. / François, C. et al. | 2013
- A544
-
Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Post-Traumatic Stress Disorder in the United StatesXie, L. / Dysinger, A. H. / Wang, L. / Du, J. / Huang, A. / Baser, O. et al. | 2013
- A545
-
Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries: THE Results of the Literature ReviewWalczak, J. / Augustyńska, J. / Miernik, K. / Stelmachowski, J. / Pieniazek, I. / Obrzut, G. / Pogroszewska, A. / Szkultecka-Debek, M. / Paulic, G. / Maric, D. et al. | 2013
- A546
-
Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in SchizophreniaBorsi, A. / Takacs, P. / Feher, L. et al. | 2013
- A547
-
How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?Massetti, M. / Vataire, A. L. / Cristeau, O. / Toumi, M. / Aballea, S. et al. | 2013
- A549
-
Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting MethylphenidateCurtice, T. G. / Greven, P. / Yeaw, J. / Sikirica, V. / Chen, Y. J. / Setyawan, J. / Makin, C. et al. | 2013
- A550
-
Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease in IndiaNegi, H. / Raval, A. / Malay, M. et al. | 2013
- A551
-
Developing an Individualized E-Health Decision Support System for Dementia Treatment and Care: The FP7 EU-Project E-Health Monitor (EHM)Schaller, S. U. / Kriza, C. / Niederländer, C. / Wahlster, P. / Kolominsky-Rabas, P. L. et al. | 2013
- A552
-
Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in Swedish Patients with SchizophreniaDepont, F. / Rouleau, A. / Osby, U. / Sobocki, P. / Milea, D. et al. | 2013
- A553
-
Impact of Autism Spectrum Disorders on the Family – A National PerspectiveVohra, R. / Madhavan, S. / Sambamoorthi, U. et al. | 2013
- A554
-
The Impact of Commodities and Extra-Articular Manifestations in Rheumatoid Arthritis PatientsDoddapaneni, S. / Khera, K. / Prabhu, V. A. / Nagappa, A. N. / Rau, N. R. et al. | 2013
- A556
-
Comparative Effectiveness of Active Versus Sham Acupuncture Versus Usual Care in the Management of Chronic, Non-Cancer Pain in Primary CareSaramago, P. / Weatherly, H. / Manca, A. / Sculpher, M. J. / MacPherson, H. et al. | 2013
- A558
-
Potential Economic Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in Russian Health Care SettingDerkach, E. V. / Avxentyeva, M. V. / Omelyanovsky, V. V. et al. | 2013
- A560
-
Work Productivity Loss Due to Rheumatoid Arthritis in Poland. Results of Cross-Sectional Study of Outpatients with Chronic Inflammatory Diseases and Comparison with Selected StudiesWladysiuk, M. / Bebrysz, M. / Rutkowski, J. / Haldas, M. / Fedyna, M. et al. | 2013
- A561
-
Biological Treatment Patterns and Associated Costs for Patients with Rheumatoid Arthritis in TaiwanWu, C. H. / Chuang, P. Y. / Tang, C. H. et al. | 2013
- A562
-
Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa TherapyRyazhenov, V. V. / Emchenko, I. V. et al. | 2013
- A564
-
Current and Future Strategy for Osteoporosis Screening and Diagnostics: Cost-Effectiveness of Frax with or without Pulse-Echo Ultrasound Measurement of Bone Mineral Density and DXA on DemandAsseburg, C. / Riekkinen, O. / Karjalainen, J. K. / Kröger, H. / Soini, E. J. et al. | 2013
- A566
-
Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients: Significant Increase of Transportation Needs and Home VisitsSzafraniec-Burylo, S. I. / Orlewska, E. / Rupinski, R. / Filipowicz-Sosnowska, A. et al. | 2013
- A567
-
Persistence & Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary: A Retrospective Cohort StudyLakatos, P. / Tóth, E. / Cina, Z. / Lang, Z. / Psachoulia, E. / Intorcia, M. et al. | 2013
- A568
-
Are Patients’ Preferences for Osteoporosis Drug Treatment Transferable Between Countries? Results from a Discrete-Choice Experiment Conducted in Two European CountriesHiligsmann, M. / Dellaert, B. / Dirksen, C. / Van der Weijden, T. / Goemaere, S. / McGowan, B. / Reginster, J. Y. / Watson, V. / Boonen, A. et al. | 2013
- A569
-
Health Outcomes and Economic Burden of Post-Knee Replacement Surgery in Osteoarthritis Patients: Comparison with Matched ControlsPignot, M. / DiBonaventura, M. et al. | 2013
- A570
-
Factors Associated with Absenteeism in Rheumatoid Arthritis Patients in Employment: Results of a Survey Among French PatientsFagnani, F. / Duburcq, A. / Woronoff, A. S. / Chauvin, P. / Cukierman, G. / Tropé-Chirol, S. / Joubert, J. M. / Bertin, P. et al. | 2013
- A571
-
Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Receiving Their First Biologic in European UnionNarayanan, S. / Baskett, A. / Lu, Y. / Hutchings, R. et al. | 2013
- A572
-
Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients: A French National Claims Database Analysis Over the Period 2009-2011Fautrel, B. / Laurendeau, C. / Joubert, J. M. / Cukierman, G. / Gourmelen, J. / Fagnani, F. et al. | 2013
- A573
-
The Resource Use Related to Hip Fractures Based on Data from ICUROSWintzell, V. / IvergÃ¥rd, M. / Tankó, L. B. / Barghout, V. / Svedbom, A. / Alekna, V. / Bianchi, M. L. / Clark, P. / DÃaz Curiel, M. / Dimai, H. P. et al. | 2013
- A574
-
The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in GermanySroczynski, G. / Esteban, E. / Engel, J. / Hillemanns, P. / Petry, K. U. / Krämer, A. / Schnell-Inderst, P. / Mühlberger, N. / Siebert, U. et al. | 2013
- A575
-
Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung CancerLuaces, P. / Sánchez, L. / Ballesteros, J. / GarcÃa, B. / RodrÃguez, P. C. / Viada, C. / Popa, X. / Crombet, T. / Lage, A. et al. | 2013
- A576
-
Review of Meta-Analysis Methods for Multinomial DataBennison, C. / van Beurden-Tan, C. / Buyukkaramikli, C. / Heeg, B. et al. | 2013
- A577
-
Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology: A Willingness-To-Participate StudyPotthoff, P. / Brown, C. / Güther, B. / Eichmann, F. et al. | 2013
- A578
-
Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and WalesRighetti, C. / Lebmeier, M. / Pennington, B. / Brereton, N. J. et al. | 2013
- A579
-
Empirical Evidence for the Validity and Reliability of Resource-Use Measures Based on Patient Recall: A Systematic ReviewThorn, J. / Noble, S. / Moore, T. / Hollingworth, W. et al. | 2013
- A580
-
The Economic Footprint of the Greek Pharmaceutical IndustryTserkezis, E. / Paratsiokas, N. / Tsakanikas, A. / Athanasiadis, A. et al. | 2013
- A581
-
Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United KingdomDemuth, D. / Nasuti, P. / Richards, C. / Gray, L. / Price, L. / Magestro, M. et al. | 2013
- A582
-
Evaluation of Dissemination of Brazilian Network for Health Technology Assessment (REBRATS)Gonçalves, L. / Souza, K. M. / Elias, F. T. et al. | 2013
- A583
-
From Clinical Trial to Real-World Evidence: A Systematic Approach to Identifying Data Sources for Observational ResearchParasuraman, B. / Tomic, K. S. / Winchester, C. C. / Westergaard, M. / Johansson, S. et al. | 2013
- A585
-
Variance Reduction Through Antithetic Variates as a Means of Developing Complex VBA Models with Reasonable Computation TimesBennett, H. / Tetlow, A. P. / McEwan, P. et al. | 2013
- A587
-
The Role of Simulation Modeling in Planning Long-Term Clinical Trials in Type 2 DiabetesFoos, V. / Grant, D. / Palmer, J. L. / Lamotte, M. / McEwan, P. et al. | 2013
- A589
-
Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung CancerStenehjem, D. / Jiao, T. / Rhien, T. / Bellows, B. K. / Kaldate, R. R. / Jones, J. / Brixner, D. et al. | 2013
- A590
-
A De Novo Economic Model to Assess the Cost and Quality of Life Consequences of an Intervention for Levodopa Induced Dyskinesia Amongst Patients with Parkinson’s DiseaseBhattacharyya, S. / Sacco, P. / Shirore, R. M. / Sonathi, V. / Thomas, S. et al. | 2013
- A591
-
Appropriate Evidence Sources for Populating Decision Analytic Models Within Health Technology Assessment (HTA): A Systematic Review of HTA Manuals and Health Economic GuidelinesZechmeister-Koss, I. / Schnell-Inderst, P. / Zauner, G. et al. | 2013
- A592
-
The Role of Half-Cycle Correction in the Models Used for Health Technology AssessmentNemeth, B. / Vincziczki, . et al. | 2013
- A594
-
A Bayesian Dynamic Model of Asthma in the Real LifeAmzal, B. / Timmaraju, V. / Castelnuovo, E. / Boucot, I. / Pribil, C. / Nachbaur, G. et al. | 2013
- A595
-
Patient Preferences in the Choice of Disease Modifying Drugs for Multiple SclerosisBergmann, A. / Lang, M. / Bischoff, C. / Schicklmaier, P. / Schiffhorst, G. / Nolting, H. D. / Rellecke, J. / Kunz, E. et al. | 2013
- A596
-
Exploring the Feasibility of the Instrument Used in Determination of Willingness-To-Pay Per Quality-Adjusted Life-Year in MalaysiaLim, Y. W. / Shafie, A. A. / Hassali, M. A. / Chua, G. N. et al. | 2013
- A598
-
Pilot Testing of the Polish Pre-Final Version of “Disabilities of the Arm, Shoulder and Hand†(Dash) QuestionnaireGolicki, D. / Krzysiak, M. / Strzelczyk, P. et al. | 2013
- A599
-
Validity of QOL Impact Attributions to Specific Diseases: A Multitrait-Multimethod ComparisonWare, J. E. / Guyer, R. et al. | 2013
- A600
-
Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials: A Content Validity and Psychometric Performance ReviewHumphrey, L. / Heron, L. / Pilling, C. / Holloway, L. / Højbjerre, L. / Strandberg-Larsen, M. / Hansen, B. B. et al. | 2013
- A602
-
A Review of Cognitive Interviewing Methodologies During Linguistic Validation of Clinical Outcome Assessments (COAs)Simon, M. / Sweeney, E. / Moravec, H. et al. | 2013
- A603
-
Parent Ratings of Ability to Consent for Clinical Trials in Fragile X SyndromeBailey, D. / Raspa, M. / Wheeler, A. et al. | 2013
- A604
-
Using Mobile Technology (mHealth) to Develop the Value Story for New Drugs, Devices and Therapies: Optimising User Engagement and Addressing Payer ConcernsTran, J. B. / Hugh-Jones, C. et al. | 2013
- A605
-
Development of a Questionnaire to Evaluate Food-Related Well-BeingGuillemin, I. / Allaert, F. A. / Arnould, B. / Capuron, L. / Dupuy, A. / Ginon, E. / Lecerf, J. M. / Prost, M. / Rogeaux, M. / Urdapiletta, I. et al. | 2013
- A606
-
Differential Item Functioning in a Satisfaction Item BankCampillo-Ã�lvarez, . / RodrÃguez-Aguilella, A. / Castejón, N. / Cuervo, J. / Rebollo, P. et al. | 2013
- A607
-
The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity DisorderMeyers, O. I. et al. | 2013
- A608
-
Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life EstimatesBujkiewicz, S. / Thompson, J. / Sutton, A. / Cooper, N. / Harrison, M. / Symmons, D. P. / Abrams, K. R. et al. | 2013
- A610
-
Adjusting for Treatment Switching in Clinical Trials When Only Summary Data Are Available – An Evaluation of Potential MethodsBoucher, R. / Abrams, K. R. / Crowther, M. J. / Lambert, P. C. / Wailoo, A. J. / Latimer, N. R. et al. | 2013
- A612
-
Research in Haemophilia B – Studies in a Rare Disease in Times of Requirements for High Evidence LevelsSchopohl, D. / Berger, K. / Schramm, W. et al. | 2013
- A613
-
Proposal of Economic Evaluation Guideline in JapanFukuda, T. / Akazawa, M. / Fukuda, H. / Igarashi, A. / Ikeda, S. / Ishida, H. / Kobayashi, M. / Moriwaki, K. / Noto, S. / Sakamaki, H. et al. | 2013
- A614
-
Systematic Review Approaches for HTA: Horses for Courses?Kenworthy, J. / Langham, J. / Chetty, M. et al. | 2013
- A615
-
Should There Be an Option to “Unrefer†Nice Single Technology Appraisals: Case Study of Aripiprazole for Bipolar I Disorder in AdolescentsUttley, L. / Kearns, B. / Stevenson, M. et al. | 2013
- A616
-
How Can Health Economic Assessment Methods Help Decision Making in Portfolio DevelopmentAkpo, H. / Popa, C. / Saka, . et al. | 2013
- A617
-
The Importance of Sensitivity Analyses in Health Technology AssessmentsHren, R. et al. | 2013
- A618
-
Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova StudyMartikainen, J. A. / Kautiainen, H. / Väätäinen, S. / Välimäki, T. / Hongisto, K. / Hallikainen, I. / Sivenius, J. / Soininen, H. / Koivisto, A. et al. | 2013
- A619
-
Practice of Cerebroprotectors Consumption in UkraineKuznetsov, I. / Iakovlieva, L. / Ribka, A. / Vasileva, A. / Kyrychenko, O. et al. | 2013
- A621
-
The Annual Treatment and Rehabillitation Costs of Patients with Paraplegia in the Private Health Care Setting in GreeceTzovolou, K. / Geitona, M. et al. | 2013
- A622
-
Cost-Effectiveness of Somatropin Administration with Increased Adherence Due to Monitoring Compared to Non-Monitored Administration in Patients with Growth Hormone DeficiencyVitova, V. / Tichopad, A. et al. | 2013
- A623
-
Cost-Effectiveness Analysis of Lacosamide Compared with Standard of Antiepileptic Care Based on Clinical Practice DataVocelka, M. / Klimes, J. / Dolezal, T. / Foitova, H. et al. | 2013
- A624
-
Treatment Adherence and Costs in Multiple Sclerosis: A Narrative Review of the LiteraturePaz, S. / Comellas, M. / Lizán, L. et al. | 2013
- A625
-
Cultural Adaptation and Validation to Spanish of the “MS Treatment Concerns Questionnaire-MSTCQâ€Galera, J. / Munteis, E. / Navarro, G. / Meca, J. / Maestre, A. / Perez, A. / Gracia, J. / Pato, A. et al. | 2013
- A626
-
Evaluating Patient Adherence Rates to Approved Disease Modifying Therapies (DMT) for Relapsing-Remitting Ms (RRMS): Operational Setup for a Multi-Country, Multi-Center StudyApecechea de Scheffer, M. / Faber, S. / Potthoff, P. / Eichmann, F. et al. | 2013
- A627
-
Additional Clinical Benefit for Patient Relevant Endpoints: Investment Disincentives by AMNOG in the Example of Parkinson’s DiseaseWalzer, S. / Holbein, B. et al. | 2013
- A628
-
Drug Compliance and Persistence in Patients with Parkinson’s Disease Treated in Primary Care in the United Kingdom: A CPRD-Based StudyBineau, S. / Guelfucci, F. / Neine, M. / Aballea, S. / Milea, D. et al. | 2013
- A629
-
A Comparison of Demographic and Clinical Variables of Down Syndrome Patients in Utah and the United StatesJiao, T. / Liou, T. G. / Young, D. / Brixner, D. et al. | 2013
- A631
-
In-Patient Hospitalizations for Chronic Kidney Disease in the United StatesAggarwal, S. / Topaloglu, H. et al. | 2013
- A632
-
Cost and Cost-Effectiveness of Treating Urgency Stress Incontinence-Results from a Randomized Controlled TrialKafri, R. / Greenberg, D. / Shames, J. / Novack, L. / Melzer, I. et al. | 2013
- A633
-
Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United KingdomMaman, K. / Neine, M. / Briquet, B. / Nazir, J. / Odeyemi, I. A. / Hakimi, Z. / Garnham, A. / Aballéa, S. et al. | 2013
- A634
-
The Impact of Sacral Neuromodulation on EQ-5D Index Scores and Costs to Manage Overactive BladderHinnenthal, J. / Siegel, S. / Noblett, K. / Mangel, J. / Bird, E. T. / Griebling, T. L. / Comiter, C. et al. | 2013
- A635
-
Antibiotic Utilization in Complicated Urinary Tract Infection in a Tertiary Care Teaching Hospital in South IndiaNair, S. / Mathew, J. / Palaye, M. / Faryabi, R. / Shetty, P. / Shivshankar, K. / Thunga, G. / Vijayanarayana, K. et al. | 2013
- A637
-
ISPOR 16th Annual European Congress Disclosure Information| 2013
- A649
-
ISPOR 16th Annual European Congress Author Index| 2013
- A665
-
Utilidad De Biomarcadores Cardiacos (Point of Care Testing) En El Area De Urgencias Y Su Impacto EconómicoContreras, I. / Lopez-Perez, A. / Mendez, G. F. / Mejia-Arangure, E. et al. | 2013
- A666
-
Effect of Health Spending, Income Inequality and Margination Index on the Efficiency of the Health System in MexicoPinzon Florez, C. E. / Reveiz, L. / Idrovo, A. J. / Reyes, H. / Diaz de Leon, C. et al. | 2013
- A667
-
Eficácia E Segurança De Ranibizumabe E Bevacizumabe No Tratamento De Degeneração Macular Relacionada a IdadeSaturnino, L. T. / Silveira, M. R. / Guerra Junior, A. A. / Acurcio, F. D. et al. | 2013
- A668
-
Implications of Global Pricing Policies of Pharmaceuticals for Access the Innovative Drugs: The Case of Trastuzumab in Seven Latin American CountriesPichon Riviere, A. / Garay, U. / Augustovski, F. / Vallejos, C. / Huayanay, L. / Navia, M. D. / RodrÃguez, A. / Oliveira, C. / Andrade, C. J. / Buendia, J. A. et al. | 2013
- A669
-
¿Puede un Cambio del 2003 en el Reglamento en el Cuadro Básico (CBM) en México Impactar la Cantidad de Estudios CientÃficos Publicados de Evaluación Económica Completos de Medicamentos (EECM) en los Últimos 10 Años?Márquez Cruz, M. / Peralta Bácenas, L. A. / Ibarra Cázares, A. E. / Rodriguez Mendoza, M. M. / Pizarro Castellanos, M. / Soto Molina, H. et al. | 2013
- A670
-
Efecto Del Seguro Popular Salud Sobre La Demanda De Servicios Prenatales En El Contexto De La Cobertura Universal, México 2012Servan-Mori, E. et al. | 2013
- A671
-
A Multi-National Survey Assessing the Relationship Between Prophylaxis Treatment and Health-Related Quality of Life Among Severe Hemophilia a Patients in Latin AmericaPerez Bianco, P. R. / Berges, A. / Linares, A. / Moreno, B. / Arvizu, J. / Brabata, C. / Xiong, Y. / Ito, D. et al. | 2013
- A674
-
Fatores Associados À Compra De Medicamentos Em BrasÃlia: Uma Análise Econométrica Com Dados Transversais De Base PopulacionalAndrade, C. H. / Wichmann, R. M. / Galvao, T. F. / Pereira, M. G. / Silva, M. T. et al. | 2013
- A675
-
Crescimento De Óbitos Pós Partos Cesarianos No Brasil Versus Partos NormaisDrago, S. / Ferreira, C. N. / Salles, G. R. / Paloni, E. D. / Santana, C. F. / Souza, C. / Bonachela, F. / Abreu, A. A. et al. | 2013
- A676
-
Análisis De Costo-Efectividad De Los Profesionales De Enfermeria Con Experiencia Laboral En Uci Versus Sin Experiencia Laboral En El Error De La Medicación Parenteral En Pacientes Adultos Hospitalizados En UciBeiza, C. / Orrego, N. / Padilla, M. F. / Arriagada, M. J. / Catalan, J. / Fau, C. / Nasabun, V. et al. | 2013
- A677
-
Assessment of Adverse Events By Using Trigger Tools in Surgery Department of an Indian Tertiary Care Teaching HospitalVilakkathala, R. / Mallayasamy, S. / Konduru, S. / Rodriques, G. / Manchanapalli, P. / Rao, A. B. et al. | 2013
- A678
-
Comparación Del Trabajo En Equipo En Salas De CirugÃa Entre Un Hospital Privado Y Uno Público De Bogotá, D.CAmaya Arias, A. C. / Eslava-Schmalbach, J. / Barajas Sierra, R. et al. | 2013
- A679
-
Exploring Income Inequality in Self-Reported Health Status in Chile After the Health Care Reform of 2005Cabieses, B. / Espinoza, M. A. et al. | 2013
- A680
-
A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar BrasileiroTanaka, F. H. / Franco, S. et al. | 2013
- A681
-
Access to Medicines Index: Measuring How Well Countries Provide Access to MedicinesShankar, R. / Hickson, S. / Gorokhovich, L. et al. | 2013
- A682
-
O Uso De Temozolomida No Tratamento De Astrocitoma De Baixo Grau – Câncer No CérebroGomes, R. M. / Ribeiro Júnior, N. G. / Costa, J. O. / Júnior, A. A. / Acurcio, F. A. et al. | 2013
- A684
-
Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil: Results from a 12-Month Retrospective Analysis of an Administrative DatabasePaloni, E. D. / Ferreira, C. N. / Asano, E. / Santana, C. F. / Pereira, M. L. et al. | 2013
- A685
-
Análisis De Costo-Efectividad De Erlotinib En El Tratamiento De Pacientes Con Cáncer Pulmonar De Células No Pequeñas, CPCNP, Con Mutación Del Gen EGFR+, En Colombiaparada Vargas, L. A. / Barbosa, D. A. et al. | 2013
- A686
-
Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe: Acesso E Impacto Econômico Em Um Hospital UniversitárioUngari, A. Q. / Pereira, L. R. / Nunes, A. A. / Peria, F. M. et al. | 2013
- A687
-
Comparación Indirecta De La Efectividad De La Combinación De Hipoglucemiantes Asociados a Metformina En Pacientes Diabéticos Tipo 2Sanchez, O. / Romero, M. et al. | 2013
- A688
-
Direct Costs of Type 2 Diabetes in Mexico from the Public Health Care Sector PerspectiveChatzitheofilou, I. / Babineaux, S. M. / RamÃrez-Gámez, J. / McDonell, A. / Vega-Hernandez, G. et al. | 2013
- A689
-
A Health Economic Analysis of the Long-Term Outcomes and Costs Associated with Using Canagliflozin Versus Sitagliptin As an Add-On to Metformin (MET) in MexicoTeschemaker, A. R. / Neslusan, C. / Puig, A. / Valencia, A. / Johansen, P. / Willis, M. et al. | 2013
- A690
-
Impacto De La Diabetes Sobre La Productividad En ArgentinaAsteazaran, S. / Elgart, J. / Gagliardino, J. J. et al. | 2013
- A691
-
Influence of One Week Education Program on the Knowledge and Approach of Pharmacy Students Towards Diabetes MellitusKhan, M. S. / Akhtar, N. / Ali, A. et al. | 2013
- A692
-
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in ChileGarcia Marti, S. / Alcaraz, A. / Valanzasca, P. / Garay Ulises, U. / McMullen, M. / Rey Ares, L. / Peirano, I. / Oksenberg Reisberg, D. / Soza Ried, A. / Poniachik, J. et al. | 2013
- A693
-
Evaluation of Factors Affecting Treatment Response and Risk Factors for Patients Diagnosed with Non-Psychotic Major Depressive Disorder: A Literature ReviewGreene, N. / Greene, M. et al. | 2013
- A694
-
The Impact of Antipsychotics Polypharmacy on Health Care Costs of People with Mental Disorders in São Paulo City, BrazilRazzouk, D. / Sousa, A. / Oliveira, G. G. / Cardoso, A. / Mari, J. J. et al. | 2013
- A695
-
Contribution of Latin America to Mental Health in PregnancyLorenzo, L. S. / Einarson, A. / Einarson, T. R. et al. | 2013
- A696
-
Costo-Efectividad Del Screening Y Tratamiento De Hipoacusia Bilateral En Recién Nacidos (Rn) En ChileCastillo-Laborde, C. / Loayza, S. / Aravena, M. / Freile, B. / Castillo-Riquelme, M. et al. | 2013
- A697
-
Impacto Presupuestal De La Enfermedad Renal Terminal En Colombia Con Un Incremento Del Número De TrasplantesRosselli, D. / Rueda, J. D. / DÃaz, C. E. et al. | 2013
- A698
-
Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Compared to Basiliximab in the Induction of Renal Transplant PatientsEscudero, P. / Misas, J. D. / Orozco-Cabal, L. F. et al. | 2013
- A699
-
Estudios Del Coste De La EnfermedadCrespo, C. / Gisbert, R. / Brosa, M. et al. | 2013
- A700
-
Analysis of Mandibular Test Specimens Used to Evaluate Bone Fixation SystemsPasseri, L. A. / Baccarin, L. S. / Casarin, R. C. / Silva, J. V. et al. | 2013
- A701
-
Disponibilidad Y Fuentes De La Información Para La Toma De Decisiones En ReumatologÃa: Uso De Los Estudios EconómicosGuzman Vazquez, S. / Rodriguez Mendoza, M. M. / Pizarro, M. / Soto, H. et al. | 2013
- A702
-
Permanent Transvenous Lead Extraction: Factors Influencing the Difficulty of the ProcedureBontempi, L. / Cerini, M. / Lipari, A. / Vassanelli, F. / Salghetti, F. / Locantore, E. / Belotti, M. / D’Aloia, A. / Vizzardi, E. / Raweh, A. et al. | 2013
- A703
-
Analysis of Consumption of Antihypertensive Drugs in Serbia from 2007 to 2011Milijasevic, B. / Milijasevic, D. / Tomic, Z. / Sabo, A. / Mikov, M. / Tomic, N. et al. | 2013
- A704
-
Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting in Mexico CityRely, K. / RamÃrez-Neria, P. / Pulido, T. / Escamilla, C. / Alexandre, P. K. / Cañedo, A. / Salinas Escudero, C. et al. | 2013
- A705
-
Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Public Health Care SystemNishikawa, A. M. / Paladini, L. / Borges, L. / Queiroga, M. / Lemos, P. / Clark, O. A. et al. | 2013
- A706
-
Correlación Entre Los Niveles De LDL-C Frente Al Riesgo De Presentación De Evento CardiovascularSimbaqueba, E. / Romero, M. et al. | 2013
- A707
-
Estimating the Impact of Statin Therapy on Direct and Societal Costs in Mexico: A Comparison to SwedenSemilla, A. P. / Kowal, S. / Storm, M. / Blanchard, T. et al. | 2013
- A708
-
Análise Comparativa Dos Anticoncepcionais Orais Com Diferentes Concentraçoes De Etinilestradiol Em Relação Aos Perfis De Eficácia E De AdesãoFreitas, M. G. / Silva, A. S. / Elias, F. T. et al. | 2013
- A709
-
Costo-Efectividad De Carbetocina En Comparación Con Oxitocina Para Prevenir Hemorragia Posparto Por AtonÃa Uterina En Pacientes Con Factores De Riesgo En ColombiaRueda, C. / Caceres, L. A. / Caicedo Navas, A. G. et al. | 2013
- A710
-
Measurements of Adherence to Oral Therapies Among Brazilian Patients: A Systematic ReviewTakemoto, M. L. / Guerra, R. / Fernandes, R. A. / Pereira, A. C. / Santos, P. M. / Amaral, L. M. / Vasconcellos, J. F. et al. | 2013
- A711
-
Atención Intercultural Del Parto Vaginal En México: Costos Económicos, Determinantes Y Retos De La Implementación De PolÃticas Efectivas En Beneficio De Las Mujeres IndÃgenasHeredia, I. / Meneses, S. / Montag, D. / Ibañez, M. / Hernández, E. / González Block, M. A. et al. | 2013
- A712
-
Costos Económicos Asociados A Secuelas De Meningitis En ColombiaAlvis-Guzmán, N. / Coronell-Rodriguez, W. / Castañeda-Orjuela, C. A. / De la Hoz-Restrepo, F. et al. | 2013
- A713
-
The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia: A Transmission Dynamic Model-Based EvaluationKothari, S. / Nwankwo, C. / Pillsbury, M. / Shcheprov, A. / Posso, H. et al. | 2013
- A714
-
Pharmacoeconomics of Cervarix Vaccines Against Human Papilloma Virus in the Republic of KazakhstanNurgozhin, T. / Gulyaev, A. / Yermekbayeva, B. / Kushugulova, A. / Akhmetova, A. / Supiev, A. et al. | 2013
- A715
-
Avaliação Do Impacto Orçamentário Com a Incorporação De Imunobiológicos Em Uma Operadora De Planos De Saúde – 2012Reis, H. P. / Magalhães, D. D. / Vieira, J. B. / Sartori, D. P. / Fonseca, D. B. / Filho, A. E. / Barsi, U. D. / Gontei, M. / Alcantara, A. C. / Maciel, J. A. et al. | 2013
- A716
-
Custos Das Fraturas Osteoporóticas No Sistema Público De Saúde BrasileiroBrandão, C. M. / Machado, G. P. / Drumond, H. A. / Alemão, M. M. / Acurcio, F. D. et al. | 2013
- A717
-
Estimated Cost Effectiveness of Lower-Dose Submicron Diclofenac Compared with Traditional Diclofenac in BrazilMladsi, D. M. / Ronquest, N. / Tannus, G. / Fonseca, M. / Saag, K. et al. | 2013
- A718
-
Qualidade De Vida Dos Pacientes Que Utilizam Medicamentos Anti-TNF Para O Tratamento De Doenças Reumáticas No Sistema Único De Saúde Em Minas Gerais, BrasilOliveira Junior, H. A. et al. | 2013
- A720
-
Burden of Multiple Sclerosis and Unmet Needs in Brazil: Cost of Illness StudySilva, N. L. / Takemoto, M. / Damasceno, B. / Fragoso, Y. D. / Finkelsztejn, A. / Gomes, M. et al. | 2013
- A721
-
Cost-Effectiveness Analyses of Natalizumab for 1st Line Versus Interferon Beta-1a 44 Mcg in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis Patients in BrazilNishikawa, A. M. / Paladini, L. / Liamas, A. L. / Bueno, C. C. / Clark, O. A. et al. | 2013
- A722
-
Evaluation of Treatment Patterns and Clinical Trials Published on Patients Diagnosed with Insomnia: A Literature UpdateGreene, N. / Greene, M. et al. | 2013
- A723
-
Health and Economic Burden of Tobacco Use in Seven Latin American Countries: Results from a Microsimulation Health Economic Model (HEM)Pichon Riviere, A. / Bardach, A. / Caporale, J. / Augustovski, F. / Alcaraz, A. / Navia, M. D. / Pinto, M. / Vallejos, C. / Peña Torres, E. / Reynales, L. M. et al. | 2013
- A725
-
Efficacy and Safety of Belimumab for the Treatment of Systemic Lupus ErythematosusBorba, H. H. / Wiens, A. / Correr, C. J. / Pontarolo, R. et al. | 2013
- A726
-
Análisis Costo-Efectividad Del Tratamiento Farmacológico Para Las Manifestaciones ClÃnicas Mucocutáneas De La Enfermedad De BehcetQuirland Lazo, C. et al. | 2013
- A727
-
Orphan Drug Access: Risk/Reward Analysis of Local Clinical Development in ChileIsmail, A. / Dummett, H. et al. | 2013
- A729
-
ISPOR 4th Latin America Conference Disclosure Information| 2013
- A732
-
ISPOR 4th Latin America Conference Author Index| 2013
- i
-
Table of Contents| 2013
- I
-
Instructions for Authors| 2013
-
Editorial Board| 2013
-
Differences in Approach to Biosimilars: Nice Versus SMC RecommendationsIzmirlieva, M. / Ando, G. et al. | 2013
-
Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality: A European OverviewHanly, P. / Soerjomataram, I. / Sharp, L. et al. | 2013
-
The Growing Role of Qualitative Interviews in Health Outcomes ResearchGuillemot, J. / Gauthier, A. / Hass, B. / Basso, F. / Cognet, M. et al. | 2013
-
Addressing Heterogeneity in Baseline Risk of COPD Exacerbations Using Meta-regressionCope, S. / Buckley, F. / Baldwin, M. / Kraemer, M. / Jansen, J. et al. | 2013
-
Challenges in Modelling the Cost Effectiveness of Interventions in Cardiovascular DiseaseBurgers, L. T. / Redekop, W. K. / Severens, J. L. et al. | 2013
-
The Measurement of Health-related Quality of Life: German Findings from the Multi-Instrument Comparison (MIC) StudySchlander, M. / Khan, M. A. / Iezzi, A. / Maxwell, A. / Richardson, J. et al. | 2013
-
Co-administration of Antipsychotics and Anti-dementia Drugs in AustriaHinteregger, M. / Füzi, J. / Reichardt, B. et al. | 2013
-
How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated with 5α-Reductase InhibitorsPovero, M. / Pitrelli, A. / Pradelli, L. et al. | 2013
-
Pharmacoeconomic Analysis of Progestogen Preparations for Threatened Abortion Treatment in UkraineTkachova, O. / Iakovlieva, L. / Mishchenko, O. / Matyashova, N. et al. | 2013
-
Protective Factors for University Students’ HealthVišnjić, A. / VeliÄÂkoviÄÂ, V. / Sokolović, D. / Ranđelović S, S. / MilovanoviÄ Â, M. et al. | 2013
-
Cost of Influenza in GermanyAnastassopoulou, A. / Wahle, K. / Hain, J. / Schroeder, C. / Ehlken, B. et al. | 2013
-
Study of Antibiotic Consumption Pattern in Hospital Acquired PneumoniaKunhikatta, V. / Rau, N. R. / Naik, A. N. / Yamsani, B. / Thunga, G. / Nair, S. et al. | 2013
-
Hospital Admissions Related to Tuberculosis in Brazil: Epidemiological and Economic Profile, from the Public Health Care PerspectiveAmaral, L. M. / Fernandes, R. A. / Takemoto, M. / Vasconcellos, J. F. / Haas, L. C. / Silva, M. A. / Menezes, L. P. et al. | 2013
-
Economic Implications of Alternative Treatments and Care Locations for Acute Bacterial Skin and Skin Structure Infections with Suspected MRSALaPensee, K. / Fan, W. / Revankar, N. / Ward, A. / Kongnakorn, T. / Pelligra, C. et al. | 2013
-
Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United StatesFan, W. / LaPensee, K. / Mao, J. / Iorga, S. / Lodise, T. P. et al. | 2013
-
Cost-Effectiveness Analysis of Empiric Liposomal Amphotericin B Versus Voriconazole in TurkeyTurner, S. J. / Senol, E. / Kara, A. / Al-Badriyeh, D. / Kong, D. C. / Dinleyici, E. C. et al. | 2013
-
Patients with Chronic Hepatitis C Virus Treated with Simeprevir Added to Peginterferon and Ribavirin Experienced Less Time with Fatigue, Depressive Symptoms, and Functional Limitations: Results from Patients in the Quest-1, Quest-2, and Promise StudiesScott, J. / Gilles, L. / Fu, M. / Brohan, E. / Amatya, R. / Jessner, W. / Beumont-Mauviel, M. et al. | 2013
-
Paper-Based and Electronic Assessment of Health-Related Quality of Life Specific to HIV Disease: A Reliability Study with the PROQOL-HIV QuestionnaireLalanne, C. / Herrmann, S. / Armstrong, A. R. / Cheung-Lung, C. / Schwartz, Y. / Chassany, O. / Duracinsky, M. et al. | 2013
-
Validation and Psychometric Evaluation of the German-Translated Hepatitis C Virus Patient Reported Outcomes (HCV-PRO) Health and Wellbeing Instrument in German HCV-Infected Patients Treated with Direct Acting Antivirals (DAAS) with or Without Ribavirin (RBV)Anderson, R. T. / Baran, R. W. / Xie, W. / Liu, Y. / Dietz, B. / Gooch, K. L. et al. | 2013
-
Barriers Underlying Limited Utilisation of Vaccines Throughout Life (Lifespan Immunisation)Ghosh, S. / Tangari, M. / Baron-Papillon, F. / Sauty, E. / Rodriguez de Azero, M. / Adel, A. l. et al. | 2013
-
The Health and Economic Effects on Public Health Due to Patients’ Default in Tuberculosis Treatment in MalaysiaFun, W. H. / Wu, D. B. / Cheong, Y. M. / Mohd Noordin, N. / Dony, J. F. / Lee, K. K. et al. | 2013
-
The Burden of Pneumonia in Malaysia, Indonesia and PhilippinesAljunid, S. / Namaitjiang, M. / Al-Abed, A. / Amrizal, M. / Zafar, A. / De Rosas-Valera, M. / Encluna, J. / Rosminah, M. / Azmi, S. et al. | 2013
-
Cost-Effectiveness Analysis of Carbapenems in Treatment Nosocomian Pneumonia in UkraineIakovlieva, L. / Bezditko, N. / Glumcher, F. / Dubrov, F. et al. | 2013
-
Inhaled Corticosteroids (ICS) in Treatment of Moderate and Severe Asthma in Russian Federation – Comparative Pharmacoeconomic StudyKrysanov, I. / Tyapkina, M. et al. | 2013
-
Economic Impact of a Smoking Cessation Program in Mexico: Enrolling Employees and EmployersHuicochea-Bartelt, J. L. / Muciño-Ortega, E. / Hernandez-Reyes, F. C. et al. | 2013
-
The Relationship Between COPD Assessment Test (CAT) and EQ-5D in a Real World Patient PopulationWood, R. / Small, M. et al. | 2013
-
Economic Evaluation of Enhanced Asthma Management: A Systematic ReviewYong, Y. V. / Shafie, A. A. et al. | 2013
-
Cost Analysis of a Fibrin Sealant Patch for Mild, Moderate and Problematic Soft Tissue Surgical Bleeding: A Hospital PerspectiveCorral, M. / Ferko, N. / Hollmann, S. / Delatore, P. / Jamous, N. / Brown, S. T. / Rubinger, D. et al. | 2013
-
The Cost of Producing a Unit of Blood in Hospitals: A Nationwide Economic Analysis for the Case of GreeceFragoulakis, V. / Stamoulis, K. / Grouzi, E. / Maniadakis, N. et al. | 2013
-
Cost-Effectiveness of Sapropterin Versus Phenylalanine Free Diet in Patients with Phenylketonuria in EgyptElSisi, G. / Elmahdawy, M. / Abaza, S. / Shalakani, A. et al. | 2013
-
Profile of Back Pain Sufferers Across 5EU CountriesAnnunziata, K. / Isherwood, G. / Sternbach, N. et al. | 2013
-
The Sustainability of Irish Pharmaceutical ExpenditureWalshe, V. / Kenneally, M. et al. | 2013
-
A Systematic Review of the Effectiveness of Taxes in Preventing Obesity TrendsManiadakis, N. / Kourlaba, G. / Kapaki, V. / Damianidi, L. et al. | 2013
-
A Lesson Learnt from Avastin®: - Bevacizumab Induced Hypertension as a Predictive Biomarker of Patient Response in Overcoming Regulatory and Health Technology Assessment (HTA) HurdlesFowler, R. C. / Street-Docherty, L. M. / Morrison, S. et al. | 2013
-
Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL): A Systematic ReviewBonthapally, V. / Yang, H. / Macalalad, A. R. / Wu, E. Q. / Lutes, R. / Shonukan, O. / Chi, A. / Huebner, D. et al. | 2013
-
A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in JapanHamashima, C. / Ogoshi, K. / Okamoto, M. / Shabana, M. / Kishimoto, T. / Fukao, A. et al. | 2013
-
The Attendance of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening ProgramBoncz, I. / Dobrossy, L. / Péntek, Z. / Kovács, A. / Budai, A. / Vajda, R. / Sebestyén, A. et al. | 2013
-
Economic Evaluation of Epoetin Alfa Hexal (Binocrit) Compared to Darbepoetin Alfa (Aranesp) in the Treatment of Chemotherapy Induced Anemia (CIA) in GermanyTurner, M. / Walsh, K. / Whitehouse, J. et al. | 2013
-
A Cost-Analysis of Stereotactic Radiotherapy in Lung CancerPerrier, L. / Morelle, M. / Pommier, P. / Plommet, N. / Beckendorf, V. / Mahé, M. A. / Lartigau, E. / Boisselier, P. / Bondiau, P. Y. / Touboul, E. et al. | 2013
-
Chemotherapy Treatment Patterns, Health Care Costs, and Mortality of Lung Cancer Patients in Taiwan – A Longitudinal Study Between 2000 and 2008Liang, F. W. / Chen, S. Y. / Tsai, C. F. / Jen, M. H. / Li, C. Y. / Wasiak, R. / Boulanger, L. / Lu, T. H. et al. | 2013
-
Cost Assessment of Metastatic and Non-Metastatic Castration-Resistant Prostate Cancer Patient-Management in SpainMorote, J. / Cozar, J. M. / Duran, I. / Gomez Veiga, F. / Leon, L. / Maroto, P. / Miñana, B. / Solsona, E. / Oyagüez, I. / Casado, M. A. et al. | 2013
-
Treatment Patterns and Costs Associated with Chronic Lymphocytic Leukemia Chemotherapy Under the Brazilian Private Health Care Perspective: A Retrospective Analysis of the Orizon DatabaseFerreira, C. N. / Paloni, E. D. / Asano, E. / Santana, C. F. / Pereira, M. L. et al. | 2013
-
Comparative Cost-Consequence Analysis of the Bivalent and Quadrivalent Vaccines Against HPV in SpainLópez Belmonte, J. L. / Cortés Bordoy, J. / Gil de Miguel, A. / Bresse, X. / Serip, S. / Nieves, D. / Bosch, X. et al. | 2013
-
Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: An Italian Cost-Effectiveness AnalysisCosimelli, M. / Golfieri, R. / Pennington, B. / Sennfält, K. et al. | 2013
-
A Cost-Effectiveness Analysis of Axitinib and Sorafenib for 2nd Line Treatment of Advanced Renal Cell Carcinoma After Failure of Cytokines in the United StatesStillman, I. O. / Ambavane, A. / Cislo, P. et al. | 2013
-
Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid TrialConnolly, M. / Currie, C. / Chang, J. et al. | 2013
-
A Framework for the Cost-Equality Analysis of Health Care ProgrammesAsaria, M. / Griffin, S. / Cookson, R. / Tappenden, P. / Whyte, S. et al. | 2013
-
Defining Eligible Patient Population in São Paulo State Based on Cleopatra Trial Inclusion Criteria: A Retrospective Analysis of Fundação Oncocentro (FOSP) Cancer Patient Registry (Registro Hospitalar Do Câncer – RHC)Tobaruella, F. S. / Maximo, M. F. / Tsuchiya, C. T. / Buschinelli, C. T. / Gonçalves, T. M. et al. | 2013
-
Results of the Post-Marketing Survey of Vildagliptin in FranceEschwège, E. / Attali, C. / Bringer, J. / Simon, D. / Bouee, S. / Kind, B. / Quere, S. / Dejager, S. / Detournay, B. et al. | 2013
-
Anti-Diabetic Medications Related Severe Hypoglycaemia Risk in Diabetes Type 1 and Type 2 – A Systematic Review of Observational StudiesPaweska, J. / Jakubczyk, M. / Barszcz, E. / Czech, M. / Niewada, M. et al. | 2013
-
Cost-Comparison Between Different Treatment Regimens in Diabetes Mellitus in Germany Based on Long Acting InsulinsAnderten, H. / Dippel, F. W. / Schneider, T. et al. | 2013
-
Adrenal Insufficiency: Burden of Disease and Cost of IllnessChauhan, R. / Lee, D. et al. | 2013
-
Cost of Microvascular and Macrovascular Complications in Peoples with Diabetes Type 1 and Type 2 in BulgariaDimitrova, M. / Doneva, M. / Vulov, V. / Manova, M. / Savova, A. / Petrova, G. / Czech, M. et al. | 2013
-
Cost of Achieving Relevant Composite Endpoint of HbA1c<7%, No Hypoglycaemia and Weight Loss of ≥3% in a 52 Week Post-Hoc Analysis of Dapagliflozin Versus GlipizideBergenheim, K. / Grandy, S. / Wygant, G. D. et al. | 2013
-
The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and WalesCharokopou, M. / McEwan, P. / Lister, S. / Callan, L. / Bergenheim, K. / Tolley, K. / Roudaut, M. et al. | 2013
-
Evaluating the Cost-Utility of Fenofibrate Treatment of Diabetic Retinopathy in AustraliaValentine, W. J. / Pollock, R. F. / Carr, E. / Aubonnet, P. / Mitchell, P. / Keech, A. et al. | 2013
-
Impact of Dosage and Seven Other Factors in the Adherence to Oral Medication in People with Diabetes Type 2 in GermanyPleguezuelo, W. i. et al. | 2013
-
Preliminary Testing of the Sagit Tool: A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical PracticeGiustina, A. / Bevan, J. / Bronstein, M. / Casanueva, F. / Chanson, P. / Petersenn, S. / Truong Thanh, X. M. / Massien, C. / Dias Barbosa, C. / Guillemin, I. et al. | 2013
-
A Relationship Between Body Mass Index and Health-Related Quality of Life Among Koreans with Diabetes: The Korea National Health and Nutrition Examination SurveyLee, J. Y. / Lee, E. K. et al. | 2013
-
Health Care Utilization Following Newly-Diagnosed Type-2 Diabetes in Sweden: A Follow-Up of 38,956 Patients in a Real Clinical SettingSabale, U. / Bodegård, J. / Sundström, J. / Svennblad, B. / Östgren, C. J. / Nilsson, P. / Johansson, G. / Henriksson, M. et al. | 2013
-
The Potential Impact of Amnog-Triggered International Referenc Pricing: A Scenario from DPP-IV InhibitorsAndo, G. / Van Mol, C. / Reinaud, F. / Honoré, A. C. et al. | 2013
-
The Effect of Reduced or Removed Copayments for Prescription Medicines on Adherence – A Systematic ReviewSinnott, S. J. / Sinnott, C. M. / Whelton, H. et al. | 2013
-
Review of the Use of Resource Use Instruments Based on Patient Recall in Relation to Other Methods of Cost EstimationRidyard, C. / Linck, P. / Hughes, D. A. et al. | 2013
-
Advanced Budget Notification (ABN): Is There a Win:Win for Manufacturers and Payers Given the Current Austerity Measures Across the EUMallinson, M. et al. | 2013
-
Long-Term Survival After Intensive Care Unit Discharge in Thailand: A Retrospective StudyLuangasanatip, N. / Hongsuwan, M. / Lubell, Y. / Limmathurotsakul, D. / Teparrukkul, P. / Chaowarat, S. / Day, N. P. / Graves, N. / Cooper, B. S. et al. | 2013
-
Canadian Private Payers’ Perceptions and Expectations of Submission Requests for Drug Reimbursement Submitted by the Pharmaceutical IndustryCharaan, M. et al. | 2013
-
Value of Life: As Perceived by Physicians and the General PublicTichopad, A. / Zigmond, J. et al. | 2013
-
Are Head-To-Head Data Necessary to Gain Reimbursement in the French National Health Care System?Patel, A. / Grosfeld, D. / Conti, C. C. / Zaidi, Q. / Furniss, S. J. et al. | 2013
-
Exploring the Key Decision Drivers Provided by HTA Agencies Rejecting Submissions with ICERs Lower Than the ThresholdWalsh, S. C. / Goodrich, K. et al. | 2013
-
The Health of Health Technology Assessment in Ireland: Five Points for ImprovementO’Mahony, J. / O’Neill, C. et al. | 2013
-
The Funding of Orphan Medicines in Europe: Payers Achilles’ Heel?Rietveld, A. / Brown, C. / Johnson, N. / Spoors, J. et al. | 2013
-
Does HTA Process Help to Achieve the Health Objectives of the Millennium? A South American AnalysisSansone, D. / Decimoni, T. C. / Etto, H. / Santos, A. M. / Araújo, G. / Fonseca, E. / Fonseca, M. et al. | 2013
-
Introducing the ENCePP Working Group (WG) on Health Technology Assessment (HTA): Enhancing the Generation of Additional Evidence for HTA ProcessesSinclair, M. / Lis, Y. / Van Engen, A. / Van Ganse, E. / Autier, P. / Daumer, M. / Ehrenstein, V. / Qizilbash, N. / Méndez, I. / Engel, P. et al. | 2013
-
The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical NeedDionne, P. A. / Ali, F. / Grobler, M. et al. | 2013
-
Characteristics of Children and Adolescents Using Proton Pump Inhibitors or Histamine-2-Receptor Antagonists: Analysis of Thin and Pharmo DatabasesRuigómez, A. / Houweling, L. M. / GarcÃa-RodrÃguez, L. A. / Penning-van Beest, F. J. / Herings, R. M. et al. | 2013
-
Peritonitis Fluid Treatment in Russian Federation: Evaluation of Economical Burden in Real Clinical PracticeYagudina, R. / Kulikov, A. / Murashko, M. et al. | 2013
-
Mortality and Medical Costs Associated with Liver-Related Diseases Among Patients with Hepatitis C Virus(HCV) Infection in TaiwanTang, C. H. / Huang, K. C. / Huang, S. Y. / Wu, Y. T. / Lin, K. D. et al. | 2013
-
Resource Utilization and Costs for Patients with Inflammatory Bowel Diseases in Italy: A Population-Based AssessmentMadotto, F. / Fornari, C. / Fiorino, G. / Ardizzone, S. / Bortoli, A. / Caprioli, F. / Cestari, R. / Conti, S. / Cortelezzi, C. / Mantovani, L. G. et al. | 2013
-
Systematic Review: The Economic Burden of Crohn’s Disease in Europe in Adults and ChildrenFloyd, D. / Langham, S. / Chevrou-Severac, H. et al. | 2013
-
Is the Use of Esomeprazole in Gastroesophageal Reflux Disease a Cost-Effective Option in Poland?Petryszyn, P. / Staniak, A. et al. | 2013
-
Systematic Literature Review of Economic Burden of Chronic Plaque PsoriasisFeldman, S. R. / Burudpakdee, C. / Gala, S. / Mallya, U. et al. | 2013
-
A Systematic Review of Patient Reported Outcomes in GlaucomaAggarwal, S. / Segal, J. / Topaloglu, H. et al. | 2013
-
Estimating the Cardiovascular Benefits of DPP-4 Inhibitors: A Simulated StudySchuetz, C. A. / Ong, S. H. / Yeung, T. / Blüher, M. et al. | 2013
-
Total and Low-Density Lipoprotein Cholesterol Levels in High Risk Patients Treated with Atorvastatin Monotherapy in the United KingdomJameson, K. / D’Oca, K. / Zhao, C. / Ramey, D. / Tershakovec, A. M. / Marrett, E. et al. | 2013
-
Cost Saving After Sutureless Replacement in Aortic Valve Stenosis: Results from a Propensity-Matched Score Analysis in GermanySantarpino, G. / Giardina, S. / Pollari, F. / Vogt, F. / Pfeiffer, S. / Fischlein, T. et al. | 2013
-
Disease Burden of Ischemic Stroke Along First Year Post-Stroke in SpainÃ�lvarez SabÃn, J. / Masjuan, J. / Yébenes, M. / Mar, J. / Oliva, J. / González-Rojas, N. et al. | 2013
-
Total Costs and Outcomes of Drug-Eluting Stent Placement with Intravascular Ultrasound (IVUS) Compared with Angiography Alone: A Cost-Effectiveness Analysis from the Perspective of the Italian Health SystemWasserman, M. / Priest, V. / Alberti, A. / Gelera, A. / Stefanini, L. / Simmonds, M. et al. | 2013
-
Prescribing Patterns of Parkinson’s DiseaseTomita, N. / Kanatani, Y. et al. | 2013
-
Initial Anticoagulation Therapy in Patients with Venous Thromboembolism and Impaired Renal Function: Results of an Observational StudyBoettger, B. / Wehling, M. / Bauersachs, R. / Amann, S. / Wilke, T. et al. | 2013
-
Simulating the Potential Impact of Improved Blood Pressure Control on Clinical and Economic Outcomes in RussiaKontsevaya, A. / Alperin, P. / Shum, K. / Eriksson, J. A. / Vigdorchik, A. / Shalnova, S. / Boytsov, S. / Hughes, D. et al. | 2013
-
Efficacy of Long-Acting Injectable Antipsychotic Therapies in Maintenance Treatment of Schizophrenia: A Mixed Treatment Comparison (MTC) of Double-Blind Randomized Clinical TrialsMajer, I. M. / Gaughran, F. / Sapin, C. / Beillat, M. / Hennequin, M. / Treur, M. et al. | 2013
-
Treatment Disparity Among Patients Diagnosed with Depressive Disorder in Working Population Based on Claims Database in JapanOnishi, Y. / Furukawa, T. A. / Hinotsu, S. / Kawakami, K. et al. | 2013
-
A Systematic Review of Cost-Of-Illness Studies and Cost-Effectiveness Analyses in Borderline Personality DisorderBrettschneider, C. / Riedel-Heller, S. / König, H. H. et al. | 2013
-
Cost-Effectiveness of Antidepressant After 24 Months of Treatment Based on Discrete Event Simulation Modeling (DESM): Agomelatine Versus Matrix Comparator of Escitalopram, Sertraline and Venlafaxine in a Thai SettingSatra, T. / Ngamthipwatthana, T. et al. | 2013
-
Pathological Gambling: A Growing AddictionDannon, P. et al. | 2013
-
Assessing the Economic Burden and Health Care Utilizations of the United States Veteran Patients Diagnosed with SchizophreniaWang, L. / Xie, L. / Li, L. / Kariburyo, M. F. / Baser, O. et al. | 2013
-
The Impact of Comorbidities on Utility Changes in Lower-Limb Osteoarthritis : Khoala StudyHosseini, K. / Gaujoux-Viala, C. / Baertschi, A. / Oudot, J. / Rat, A. C. / Guillemin, F. et al. | 2013
-
The 3D O-Arm Surgical Imaging System with Navigation Effectively and Economically Addresses the Challenges of Spinal Stabilization ProceduresAnnoni, E. / Joedicke, H. / Barnett, G. S. et al. | 2013
-
Evaluating the Efficacy of Biosimilar Infliximab with the ACR50 Response in Patients with Rheumatoid Arthritis; A Meta-Analysis in Bayesian FrameworkBrodszky, V. / Gulacsi, L. / Balogh, O. / V. Hevér, N. / Baji, P. / Péntek, M. et al. | 2013
-
Outpatient Medical Costs, Indirect Costs, and Family Burden of Osteoporosis Fracture in ChinaYang, Y. / Du, F. / Lu, T. / Xie, Z. / Xu, W. / Huang, Q. / Ye, W. W. / Burge, R. et al. | 2013
-
Cost-Effectiveness Analysis of Incorporation of the HPV Vaccine to the National Immunization Program / NIP of BrazilNovaes, H. M. / azevedo e Silva, G. / Ayres, A. / Itria, A. / Rama, C. / Sartori, A. M. / De Soarez, P. C. / Clark, A. / Resch, S. et al. | 2013
-
Evaluación Económica Del Uso De La Perfusión Aislada De Extremidad Con Tasonermia En Pacientes Con Sarcoma De Tejido Blando IrresecableGay, J. G. / Jones, K. / Valencia, C. / Garcia, D. et al. | 2013
-
Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and MexicoSandorff, E. / Ziai Buetas, A. / Severi Bruni, D. et al. | 2013
-
Direct Costs of Type 2 Diabetes from the Brazilian Public Health Care Sector PerspectiveHnoosh, A. / Babineaux, S. M. / Piras de Oliveira, C. / McDonell, A. / Vega-Hernandez, G. et al. | 2013
-
Trends in Health Care Resources Utilization, Cost and Medication Selection in the Treatment of DiabetesLachaine, J. / Beauchemin, C. et al. | 2013
-
Cost-Effectiveness of Paricalcitol Versus Parathyroidectomy for Secondary Hyperparathyroidism to Chronic Kidney Disease in MexicoSanchez-Casillas, J. L. / Ramirez-Lopez-De-N, M. G. et al. | 2013
-
Health Economic Benefits of Sensor Augmented Insulin Pump Therapy in ColombiaGomez, A. / Alfonso-Cristancho, R. / Prieto-Salamanca, D. / Valencia, J. E. / Lynch, P. / Roze, S. et al. | 2013
-
Costo Del Automonitoreo Glucémico En Pacientes En Tratamiento Combinado Oral Y Con Insulina En ArgentinaElgart, J. / Gonzalez, L. / Gagliardino, J. J. / Rucci, E. et al. | 2013
-
The Cost-Effectiveness and Cost-Utility of Paliperidone Palmitate in the Treatment of Schizophrenia in GuatemalaObando, C. A. / Gonzalez, L. / Muschett, D. et al. | 2013
-
The Direct Costs of Drug-Induced Skin Reactions in PolandWisniewska, N. / Szkultecka-Debek, M. / Owczarek, W. / Paluchowska, B. / Jahnz-Rozyk, K. et al. | 2013
-
A Evolução Da Rede Brasileira De Avaliação E Tecnologia Em SaúdeGonçalves, L. / Souza, K. M. et al. | 2013
-
Ãnalise De Significância Do Banco De Dados De Hospitais Particulares BrasileiroFerreira, C. N. / Souza, C. / Bonachela, F. / Abreu, A. A. / Paloni, E. D. / Drago, S. / Salles, G. R. / Santana, C. F. et al. | 2013
-
Treatment Costs of Ischemic Stroke Prevention and Management in Patients with Atrial Fibrillation (AF) in Latin America: Argentina, Brazil, Chile, and VenezuelaSoriano, M. A. / Leyva-Bravo, V. / González-Rojas, G. L. / Medina-Farina, M. / Duarte, M. A. et al. | 2013
-
Disposición a Pagar Y Análisis De Conjoint Para Determinar Las Preferencias Por Los Productos Medley En MéxicoCamacho, A. / Soto, H. et al. | 2013
-
Cost Effectiveness Evaluation of a Rotavirus Vaccination Program in ArgentinaGarcia Marti, S. / Alcaraz, A. / Valanzasca, P. / Mc mullen, M. / Standaert, A. / Garay, U. / Lepetic, A. C. / Gomez, J. A. et al. | 2013
-
Costo-Efectividad De Las Cintas De Uretra Media Comparadas Con El Tratamiento Convencional De La Incontinencia Urinaria Femenina De Esfuerzo En ColombiaLopez-Ramos, H. E. / Garcia-Perdomo, H. / Prieto-Martinez, V. / Rosselli, D. / Cortes, V. et al. | 2013
-
Evolución Del Consumo Y Ventas De Antibióticos En Chile 1998-2012Villagra, G. / Jirón, M. et al. | 2013
-
Custo-Efetividade Do Tratamento Para Osteoporose Na Pos-Menopausa No BrasilBrandão, C. M. / Machado, G. P. / Saturnino, L. T. / Oliveira, G. L. / Acurcio, F. D. et al. | 2013
-
Análisis De Costos Mediante Un Modelo Lineal Generalizado De Pacientes Mexicanos Con Sindrome De WestPizarro, M. / Soto, H. / Bastida-Mercado, E. / Salazar, A. et al. | 2013
-
Which Cystic Fibrosis Inhaled Antibiotic Medicine Features Matter Most to Adult Patients and Parents of Pediatric Patients?Mohamed, A. F. / Johnson, F. R. / Balp, M. M. / Calado, F. et al. | 2013
-
Graphic Health Warnings on Cigarette Packs in Qatar: Pre-Implementation Awareness and Perception Among the General PublicAwaisu, A. / Hagi, A. / Ashour, M. A. / Kheir, A. N. et al. | 2013
-
Affordability of Antihypertensive Treatment in MexicoLemus, F. / Rivas, R. et al. | 2013
-
Economic Impact Associated with a Biological Therapy Prioritization Protocol in Rheumatoid Arthritis Patients in the Hospital of SaguntoBorrás-Blasco, J. / Gracia-Pérez, A. / Castera, D. E. / Rosique, J. D. / Abad, F. J. / González, l. A. et al. | 2013
-
Uncovering the Gap Between Model Validation Recommendations and PracticeKleintjens, J. / Akpo, H. et al. | 2013
-
4-Valent Vaccine Patients – Statistical Assessment of a New Estimation MethodologySchroeder-Bernhardi, D. / Grunow, S. / Zoellner, Y. F. et al. | 2013
-
Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis: What to Do When a Biologic FailsMauskopf, J. A. / McBride, D. / Mallya, U. / Feldman, S. R. et al. | 2013
-
Assessing the Significance of HbA1c Durability in Cost Effectiveness Analysis of 2nd Line Oral Therapies in the Management of Type 2 DiabetesFoos, V. / McEwan, P. / Palmer, J. L. / Lamotte, M. / Grant, D. et al. | 2013
-
Generating the Cost-Effectiveness Frontier When Costs and/or Benefits Are Correlated Across StrategiesTeljeur, C. / O’Neill, M. / Harrington, P. / Ryan, M. et al. | 2013
-
The Determinants of Innovation – A Brief Study of Issues Influencing Innovation in the Pharmaceutical IndustryGhouse, R. et al. | 2013
-
ePRO Migration and Usability Testing of Patient-Reported Outcome (PRO) MeasuresWilkins, G. / Two, R. / Churchman, D. / Jenkinson, C. / Dawson, J. et al. | 2013
-
Functional Observation with TTO in Chronic DiseasesKövér, K. / Meszaros, A. et al. | 2013
-
Mapping from PDQ-39 and PDQ-8 Onto EQ-5D Utility Index in Patients with Parkinson’s Disease: Extended AnalysisKalabina, S. / Curry, A. S. / Milligan, G. / Jackson, J. / Merikle, E. / Filipovic, I. et al. | 2013
-
Mode Equivalence of Interactive Voice Response (IVR) and Paper Versions of the Brief Pain Inventory (BPI) “Worst Pain†Item in Metastatic Castrate Resistant Prostate Cancer (mCRPC) Evaluated Conceptually Using Qualitative MethodsBennett, A. / Eremenco, S. / Heon, N. / Scheffold, C. / Schimmoller, F. / Weitzman, A. / Basch, E. et al. | 2013
-
A Comparison of the Relative Weights of Health Domains on Global Retrospective and Experienced Health and Well-BeingJoore, M. A. / Delespaul, P. A. / White, M. P. / Maes, I. et al. | 2013
-
Can We Use the EQ-5D Only for Assessing the Quality of Life of Patients with Osteoporosis?Tadic, I. / Lakic, D. / Odalovic, M. / Tasic, L. / Vujasinovic Stupar, N. / Stevanovic, D. / Petrova, G. / Krajnovic, D. et al. | 2013
-
The E-Health Impact Questionnaire: Developing a Tool to Measure the Effects of Using Health-Related WebsitesKelly, L. / Ziebland, S. / Jenkinson, C. et al. | 2013
-
The Impact of DSM-5 on the Development of Drugs to Treat SchizophreniaMeyers, O. I. et al. | 2013
-
Holistic Data Generation and Synthesis for HTA Assessment: Bringing Together Comparative Effectiveness Research, Personalised Medicine and Patient-Centred Outcomes ResearchLangham, S. / Ratcliffe, M. / Floyd, D. et al. | 2013
-
Comparative Efficiency Research: Meta-Analysis of Cost-Effectiveness StudiesCrespo, C. / Monleon, A. / DÃaz, W. / Rodriguez, C. / Brosa, M. / Rios, M. et al. | 2013
-
Use of the French Claims and Hospitalisations Database to Estimate the Prevalence and Incidence of Parkinson’s Disease in FranceBlin, P. / Dureau, C. / Grolleau, A. / Corbillon, E. / Jové, J. / Lassalle, R. / Poutignat, N. / Foubert-Samier, A. / Droz, C. / Moore, N. et al. | 2013
-
Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United StatesBonafede, M. M. / Johnson, B. H. / Watson, C. et al. | 2013
-
Burden of L-Dopa-Induced Dyskinesia in Parkinson’s Disease Patients (PD-LID) in France – the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation)Kryskowiak, P. / Viallet, F. / Brefel-Courbon, C. / Durif, F. / Ory-Magne, F. / Tison, F. / Bourdeix, I. / Rérat, K. / Willemin, L. et al. | 2013
-
Direct and Indirect Costs of MS in IrelandFogarty, E. / Walsh, C. / McGuigan, C. / Barry, M. / Tubridy, N. et al. | 2013
-
Health Related Quality of Life (HRQL) in Parkinson’s Disease: The Impact of ‘On’ and ‘Off’ TimeKerr, C. / Howard, C. E. / Johnston, K. / Smith, H. T. / Lloyd, E. / Cooper, J. A. / McIntosh, E. / Lloyd, A. J. et al. | 2013
-
Evaluating Fatigue in Fibromyalgia: Development and Validation of the Daily Diary of Fatigue Symptoms in Fibromyalgia (DFS-Fibro)Burbridge, C. / Symonds, T. / Humphrey, L. / Arbuckle, R. / Hirsch, I. / Whelan, L. et al. | 2013
-
Quality of Life in Patients with Multiple Sclerosis in SlovakiaBielik, J. / Tomek, D. / Tomekova, K. / Novak, I. / Andrasova, E. et al. | 2013
-
Comparisons of the Clinical Effectiveness of Treatments for the Symptoms Associated with Overactive Bladder (OAB)Edwards, S. J. / Karner, C. / Trevor, N. / Barton, S. / Nherera, L. et al. | 2013
-
Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Chronic Kidney Disease in the United StatesWang, L. / Xie, L. / Du, J. / Huang, A. / Baser, O. et al. | 2013
-
Health Related Quality of Life of Patients with Bladder Cancer in HungaryBrodszky, V. / Szantó, . / Balló, A. / V. Hevér, N. / Gulácsi, L. / Tóth, G. / Buzogány, I. / Péntek, M. et al. | 2013
-
Evaluation of a Process of Care Model for Open Intravesical Ureteral Reimplantation from a Contemporary Health Care PerspectiveEllsworth, P. / Butler, C. et al. | 2013
-
Treatment of Type 2 Diabetes with Saxagliptin/Metformin Extended-Release (XR): Budget Impact Analysis in ArgentinaElgart, J. / Gonzalez, L. / Aiello, E. C. / Gagliardino, J. J. et al. | 2013
-
Análisis De Costo-Efectividad Del Uso De Estatinas En La Prevención De Eventos Cardiovasculares En ColombiaMould, J. / Ordoñez, J. / Gutierrez-Ardila, M. V. / Vargas Zea, N. et al. | 2013
-
Cost-Effectiveness of Various Combinations of Human Papillomavirus (HPV)-Based Primary Screening Testing, Including Genotyping for HPV 16/18, for Cervical Cancer Screening in MexicoCorro, A. / Ramirez, A. / Williams, E. / Huang, J. / Souza, F. H. et al. | 2013
-
Self-Reported Health Status and EQ-5D-3L Values of the Argentine Population: Comparing 2005 Versus 2009 National Risk Factor SurveysAugustovski, F. / Rey Ares, L. / Gibbons, L. et al. | 2013
-
Ações De Farmacovigilância: Relato De Notificações De Medicamentos À Agência Nacional De Vigilância Sanitária (ANVISA) – BrasilCosta Paulo, P. T. / Pedrosa, M. D. / Melo, R. D. / Fernandes, A. D. et al. | 2013
-
Poder Popular Y Regulación Del Precio De Los Medicamentos En VenezuelaAdesso, G. et al. | 2013
-
Costo E Impacto Presupuestal Del Tratamiento Del Cáncer De Púlmon De Celulas No Pequeñas Del Tipo Adenocarcinoma Con Grado Ecog 0,1,2 En Estadio Iv Con Mutación + (EGFR O ALK) Con Terapias Blanco En MéxicoPeniche-Otero, G. / Herrera-Rojas, J. / Gryzbowski, E. / Muciño-Ortega, E. / Galindo-Suárez, R. M. et al. | 2013
-
Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in MexicoWehler, E. / Leyva, V. / Bertwistle, D. / Munakata, J. / Valencia, A. / Hernandez, A. / de la Torre, L. / Gonzalez, L. et al. | 2013
-
Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) StudyCortesi, P. A. / Olivieri, I. / de Portu, S. / Salvarani, C. / Cauli, A. / Lubrano, E. / Spadaro, A. / Cantini, F. / Cutro, M. / Mathieu, A. et al. | 2013
-
Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal OsteoporosisKarlsson, L. / Lundkvist, J. / Intorcia, M. / Psachoulia, E. / Ström, O. et al. | 2013
-
Beta-Thalassemia Patients Survey on Deferrization TherapyXia, S. / Huang, L. / Zhang, W. et al. | 2013
-
Short Run Dynamics of Inadequate Pain Relief (IPR): Evidence from a European Multinational Survey of Real World Therapies (SORT)Mavros, P. / Black, C. M. / Peloso, P. M. / Stokes, L. / Philips, C. / Moore, A. / Conaghan, P. / Rannou, F. / Arden, N. / van de Laar, M. et al. | 2013
-
Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic and Biologic-Naïve Patients Considered Biologic-Suitable in the United StatesNarayanan, S. / Baskett, A. / Lu, Y. / Hutchings, R. et al. | 2013
-
Time Dependent Resource Use and Costs Associated with Different States of Disease in Patients Diagnosed with HER-2 Positive Metastatic Breast CancerFrederix, G. W. / Severens, J. L. / Hövels, A. M. / van Hasselt, J. G. / Raaijmakers, J. A. / Schellens, J. H. et al. | 2013
-
Carbon Cost-Effectiveness of Cocooning Immunization Against Pertussis in England and Wales: An Ecological PerspectiveTerlinden, A. / Renson, B. / Ponder, C. / Poirrier, J. E. / Curran, D. et al. | 2013
-
Unchartered Territory – Analysis of Cross-Border Service Provision Within Public Health SystemsMoran, P. / Teljeur, C. / Murphy, L. / O’Neill, M. / Harrington, P. / Ryan, M. et al. | 2013
-
Challenges of Conducting Economic Evaluations Using Linked Electronic Health Records - CPRD and HES in the United KingdomAsaria, M. / Walker, S. / Sculpher, M. J. / Palmer, S. / Manca, A. / Abrams, K. R. / Hemingway, H. / Denaxas, S. / Morley, K. I. / Shah, A. et al. | 2013